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SUMMARY 
 
Campylobacter jejuni, an important food-borne human bacterial pathogen in 
industrialized countries and in the developing world, the leading cause of bacterial 
diarrhoea. The infection may be accompanied by fever and abdominal cramps and, 
as a post-infection complication, in rare cases Guillain-Barré syndrome might 
emerge. In contrast, C. jejuni is only a commensal in poultry, where the pathogen 
predominantly resides in the cecum which contains many anaerobic fermentative 
bacteria. Within these natural habitats, C. jejuni is able to metabolize products like 
free amino and keto acids that have been generated by these bacterial species or 
from the host himself. 
 
In order to identify genes which are related to the invasion of host cells by the 
pathogen, 660 clones of a transposon mutant library generated in the clinical C. 
jejuni isolate B2 were screened. Thereby, a clone with a transposon insertion in gene 
cj0952c was identified. As in the sequenced C. jejuni strain NCTC 11168, the 
respective protein together with the gene product of adjacent gene cj0951c consists 
of two transmembrane domains, a HAMP domain followed by C-terminal putative 
MCP domain together believed to act as a chemoreceptor, designated as Tlp7. This 
thesis describes that genes cj0952c and cj0951c are important for the invasion of 
host cells by the pathogen. In addition, it is clearly shown that both genes are not 
translated as one protein in C. jejuni isolate B2 contradicting the idea of a postulated 
read-through mechanism. Moreover, these genes are responsible for reduced 
motility of C. jejuni and alter the chemotactical behavior of the pathogen towards 
formic acid. Finally, growth curve analysis indicates that these genes are not related 
to the utilization of formic acid by formate dehydrogenase. 
 
A second gene investigated in this thesis with regard to reduced infectivity of C. 
jejuni isolate B2 is cj0005c, which encodes a molybdopterin oxidoreductase. 
Together with the monohaem cytochrome c oxidoreductase subunit encoded by 
cj0004c, both subunits constitute a sulphite: cytochrome c oxidoreductase (SOR). 
VII 
 
Since C. jejuni lacks the glycolytic enzyme phosphofructokinase, glucose cannot be 
catabolized and other products serve as electron donors, e.g. succinate, malate, 
formate, D-lactate, hydrogen and NAD(P)H. The possession of a sulphite oxidation 
system is believed to be important for C. jejuni to survive in food which has been 
treated with sulphite for preservative reasons, as well as in humans since it has 
been shown that sulphite is also released by neutrophils as part of the host defense. 
In this thesis SOR is docummented to be an important virulence factor of C. jejuni by 
reducing the motility of the pathogen and by the downregulation of C. jejuni genes 
known to belong to the virulence repertoire of the pathogen. 
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1 INTRODUCTION 
1.1 Campylobacter jejuni 
 
The genus Campylobacter belongs to the epsilon proteobacteria class, order 
Campylobacterales and to the family Campylobacteriaceae, which consists of 16 
species where Campylobacter jejuni is known as the most common causative 
agent of gastroenteritis. C. jejuni is Gram negative, curved or rod shaped with a 
size of 0.2 to 0.8 µm and a single flagellum at one or both ends. An electron 
microscopy image of C. jejuni cells is shown in Fig 1.1. 
 
 
Figure 1.1  Electron microscopy image of C. jejuni cells 
The figure reflects the typical spiral shape of C. jejuni bacteria (Courtesy: Prof. D. E. Taylor, 
University of Alberta, Canada and Adopted with permission from Lai-King N.G. et al., 1985; J. of 
Bacteriology 338-343) 
 
The genome of C. jejuni has a size of approximately 1.6-1.7 Mbp and an AT ratio 
of about 70 % (Parkhill et al., 2000). C. jejuni needs a special microaerophilic 
environment at 37-42 0C for its growth. Poultry is the most prominent reservoir for 
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Campylobacter with microaerophilic conditions and a body temperature between 
41 and 44 0C. There are numerous transmission routes for Campylobacter spp. to 
infect humans. Most infections usually account through the consumption of 
undercooked contaminated poultry and, to a lesser extent, through the ingestion 
of contaminated meat from cattle, sheep, pigs, goats or seafood (Yamazaki et al., 
2009; Whyte et al., 2004). The ecological cycle of C. jejuni is shown in Fig 1.2. 
 
 
 
Figure 1.2  The diagram of C. jejuni ecological cycle 
Ecological cycle shows that livestock, wild birds and chicken constitute the major reservoirs of C. 
jejuni. It colonizes the gastrointestinal mucosa of chicken; from there it is transferred between 
chicks within a flock through the faecal–oral route or enters the water supply.  Humans are directly 
infected by C. jejuni through the consumption of contaminated animal products such as meat, 
particularly poultry or drinking of contaminated water or unpasteurized milk. In humans, C. jejuni 
invades the intestinal epithelial layer, which can result in inflammatory diarrhoea [Adopted with 
permission from Young et al., 2007; Nat Rev Microbiol 5:665-679).  
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1.1.1 C. jejuni caused diseases 
Campylobacter jejuni is one of the most common causes of human diarrheal 
diseases. The incubation period can range from one to eight days with a typical 
time frame of three to four days (Skirrow et al., 1995). Clinical manifestation can 
range from watery to bloody diarrhoea often associated with acute abdominal 
cramps and fever. The peak of illness usually lasts for 24–48 hrs before it 
gradually resolves over a week, but convalescence may also be prolonged. The 
incidences of campylobacteriosis are increasing worldwide. Meanwhile, the 
number of cases often exceeding those of salmonellosis and shigellosis 
(Altekruse, 1999; Bryan and Doyle, 1995) with incidence rates in the United States 
of estimated 2.5 million cases and in Germany of more than 60,000 cases per 
year (Friedman et al., 2000). Age also determines the pattern of infection, the 
incidence under an age of four years is significantly higher than it is observed in 
the 19-29 year old patient group. There are peak incidences during the summer 
months indicating maximum replication rate of C. jejuni at higher temperatures 
(Asrat et al., 1999; Banmali et al., 2006).  
 
The infection becomes subclinical, when patients frequently exposed to 
Campylobacter evolve immunity. This is most observed in children in developing 
countries, which are repeatedly infected, but also in certain western countries 
among people that are working in poultry abattoirs. In certain diseases e.g. 
diabetes, HIV infection, cancer in which the immune system is impaired, the risk 
of Campylobacter infection increases. In HIV positive patients, e.g. the risk of 
disease is 40 times higher than compared to normal patients (Sorvillo at al., 
1990). 
 
Like other enteropathogenic bacteria, C. jejuni can cause post-infectious 
manifestations like urticaria, erythemanodosum and reactive arthritis. In addition, 
C. jejuni has been recently described to be associated with immunoproliferative 
small intestinal diseases (Lecuit, 2004). The Guillain-Barré syndrome (GBS) is 
considered to be the most important post-infectious manifestation with reported 
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incidences of 1.2 to 1.9 per 100,000 in Europe alone (Rees, 1998; Govoni, 2001). 
Increasing rates of GBS are reported with advancing age of 75 years of about four 
per 100,000 compared to less than one per 100,000 in patients younger than 18 
to 30 years. The most common subtypes are acute motor axonal neuropathy 
(AMAN), acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and 
when sensory fibers are affected, acute motor and sensory axonal neuropathy 
(AMSAN) (Asbury et al., 1969; McKhann et al., 1991; Griffin, 1996). The main 
symptoms of GBS are rapidly progressing bilateral and relative symmetrical 
weakness of the limbs and impairment of the respiratory muscles. Frequently, pain 
occurs from mild to severe (Asbury and Cornblath, 1990). 
 
A reduction of the infection rate of C. jejuni in humans will be related to the 
knowledge of biological aspects and, in particular, to the knowledge of virulence 
factors, which are directly responsible to the pathogenesis of the disease. 
However, less is known about the pathogenesis of the disease at the molecular 
level. Meanwhile, genome sequences of different Campylobacter strains are 
available, which open new directions in Campylobacter research (Parkhill et al., 
2000). 
 
1.2 General features of virulence associated factors of C. jajuni 
 
1.2.1 Flagellum 
Campylobacter jejuni possesses a polar flagellum which mediates motility that, in 
turn, plays a very vital role for host colonization and host-cell invasion (Yao et al., 
1994; Ormonde et al., 2000). Early studies indicated that aflagellated C. jejuni 
mutants illustrate clearly reduced internalization into the host cells in-vitro (Yao et 
al., 1994; Wassenaar and Blaser, 1999). The flagellum of Campylobacter jejuni is 
composed of O-linked glycosylated flagellin. It was observed that for the 
expression of a functional flagellum different strains of C. jejuni are possessing 
different numbers of genes, e.g. 50 (cj1293 to cj1342) adjacent to flaA and flaB, in 
case of C. jejuni strain NCTC 11168 (Parkhill, 2000). In contrast, in C. jejuni strain 
5 
 
81-176, the flagellin O-linked glycosylation locus comprises only 26 genes 
(Guerry, 2006; Goon et al., 2003). Recent studies have suggested a two-
component system comprised of the sensor FlgS and the response regulator FlgR 
to be the major control on flagella expression in C. jejuni. The composition of the 
cell wall and the flagellum of C. jejuni is shown in Fig. 1.3. 
 
 
 
Figure 1.3  A cross-sectional appearance of the C. jejuni cell wall 
 The figure illustrates the flagellum, outer membrane protein and its associated 
lipooligosaccharides, capsule and the O- and N-linked glycans [Adopted with permission from 
Young et al., 2007; Nat Rev Microbiol 5:665-679]. 
 
Specialized type-III-secretion systems have been shown to be important for 
virulence of many Gram-negative enteric pathogens. However, genomic studies 
have indicated that C. jejuni strains lack these systems (Galan and Collmer, 
1999). However, there are several reports that the flagellum can function to 
secrete virulence associated proteins. One of these proteins that were identified 
along with seven other proteins is CiaB (Konkel et al., 1999). A ciaB mutant of C. 
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jejuni strain F38011 has no obvious motility defects, but is unable to secrete any 
of the Cia proteins. Moreover, the mutant has a 50-fold reduced invasion capacity 
compared to the parental strain F38011 (Konkel et al., 1999). In contrast, a 
mutation of ciaB in C. jejuni strain 81–176 had no significant effect on the invasion 
of INT407 cells (Goon et al., 2006). These different observations might be due to 
variable invasion mechanisms among strains, cell lines used or methodologies 
(Goon et al., 2006). At least, a minimum flagella structure is required for the 
secretion of Cia proteins. In an flhB mutant secretion of the Cia proteins was not 
detected. 
 
Recent studies have suggested that in both, in a flaA mutant and in a flaB mutant 
secretion occurs, but not in a double mutant that lacks all filament structure 
(Konkel et al., 2004). Recently, secreted proteins FlgP and FlgQ, have been 
described to be important for flagellar motility in C. jejuni but their functional 
mechanisms remain unclear. Furthermore, they show no similarity with already 
characterized proteins (Sommerlad and Hendrixson, 2007).  
 
1.2.2  Invasion 
The invasion capability of C. jejuni is an important virulence factor. Intracellular 
bacterial survival and replication has been observed extensively using mammalian 
cell tissue. Also, the results of intestinal biopsies of patients have demonstrated 
that C. jejuni invades the cells of the gut. Thereby, the ability of C. jejuni to invade 
host cell has been shown to be strain depended (Newell et al., 1985). Statistically, 
significant differences were observed in the ability of host cell invasion of C. jejuni 
strains from individuals with non inflammatory diarrhea versus individuals with 
colitis (Everest, 1992). In addition, it was observed that some C. jejuni strains 
show a very low level of invasion (Konkel et al., 1992), suggesting the use of 
different mechanisms for cell entry similar to those observed for different 
Chlamydia serovars (Byrne and Moulder, 1978; Clausen et al., 1997). In order to 
characterize the interaction of C. jejuni with host cells in vitro, invasion assays, 
largely based upon gentamicin protection, have been used to study extensively 
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the invasiveness of C. jejuni in various cell lines including HeLa, HEp2, INT 407 
and Caco-2 cells (Fauche`re et al., 1986; Konkel and Joens, 1989; Wassenaar et 
al., 1991; Everest et al., 1992; Russell and Blake, 1994). Furthermore, Russell et 
al., (1993) reported based on an experimental primate model of Macaca mulatta - 
the ability of C. jejuni to invade colonic epithelial cells and to cause diarrhea. 
Moreover, mucosal damage as a result of a C. jejuni invasion of colonic epithelial 
cells has been reported in different animal models. 
 
 
 
 
Figure 1.4 Pathogenesis model of C. jejuni. 
(1) Initially, C. jejuni adheres at the apical cell surface at the peri-junctional region. (2) Where it 
secretes putative invasion effectors into the host cell. (3) Disruption of cortical actin filaments and 
an extension of microtubules (MTs) are mediated by host signalling cascades to form a membrane 
protrusion. (4) Endocytosis of the bacterium via membrane invagination. (5) Membrane bound C. 
jejuni vacuole moves to the basolateral surface through dynein along MTs. (6) For exocytosis (7) 
Again re-enter the epithelium basolaterally. (8) Interleukin (IL)-8 secretions of infected cells, and 
subsequent proliferation of lymphocytes from the lamina propria. (9) Uptake of C. jejuni into 
macrophages and local dissemination [Adopted with permission from Kopecko, et al. 2001; 
TRENDS in Microbiology 9:389-396].  
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1.2.3  Chemotaxis 
Chemotaxis is the ability of an organism to move toward or away from a chemical 
stimulus. Thereby, chemotaxis and cellular motility contribute to the colonization 
and virulence of pathogenic bacteria (Josenhans and Suerbaum, 2002). It is also 
reported that chemotactic mediated motility plays an important role in disease 
progression of virulent organisms, e.g. Vibrio cholerae (Lee et al., 2001). Several 
studies demonstrated the ability of C. jejuni to sense its external environment 
through chemical gradients, indicating that chemotaxis is an important virulence 
factor which plays a crucial role in the colonization and pathogenicity (Yao et al., 
1997). C. jejuni was found to exhibit a number of chemoreceptors for the detection 
of chemoattractants and chemorepellents such as the amino acids L-glutamate, L-
aspartate, L-cysteine, and L-serine, the carbohydrate L-fucose, and the organic 
acids pyruvate, fumarate, succinate, malate, citrate and ketoglutarate (Hugdahl et 
al., 1988). 
 
The attraction and repulsion of chemicals is sensed by trans-membrane methyl-
accepting chemotaxis proteins (MCPs) which transmit the information to the 
flagellum motor via the histidine kinase CheA and the response regulator CheY. C. 
jejuni strain NCTC 11168 possesses altogether two aerotaxis genes and ten 
genes for putative chemoreceptor molecules, designated Tlps for transducer-like 
proteins (Marchant et al., 2002). It has been reported that colonization in chickens 
and the invasion of human epithelial and chicken embryo cells are severely 
impaired in C. jejuni strains with mutations in tlp1, tlp3, docB, and docC (Christina 
et al., 2009). The importance of the chemosensory receptors of C. jejuni for 
virulence has also been described with a mutant lacking Tlp9 (Cj1189c or CetB), 
which shows invasion deficiency of human tissue culture cells (Golden and 
Acheson, 2002). Furthermore, Tlp10 (Cj0019) and Tlp4 (Cj0262c) were found to 
be necessary for wild-type colonization of the chick gastrointestinal tract 
(Hendrixson and DiRita, 2004). Altogether, although chemotaxis has been 
demonstrated to be important for C. jejuni (Hugdahl et al., 1988; Takata et al., 
1992), the mechanistic source of the sensory control of motility is yet to be 
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elucidated. 
 
1.2.4 Cytolethal distending toxin  
Protein toxins are a well defined source of bacterial virulence with specific effects 
on normal host cell function. Mostly, they act on membranes or interfere with 
intracellular signaling by binding with specific signaling proteins thereby facilitating 
the process of infection. Although the genome of C. jejuni has been sequenced, 
yet only a few potential virulence factors produced are known (Parkhill et al., 
2000). One of these is the cytolethal distending toxin (CDT), which is produced by 
a number of Campylobacter species, including C. jejuni, C. lari, C. coli, C. fetus, 
and C. upsaliensis, (Johnson and Lior, 1988; Mooney et al., 2001). This toxin was 
observed to induce cell distension in different mammalian cells such as HeLa, 
Chinese hamster ovary (CHO), Caco2 cells and other, which is characterized by 
elongation, swelling and eventually cell death (Whitehouse et al., 1998; Shenker 
et al., 1999). However, it was observed that not all cell types were sensitive to 
CDT because NIH 3T3 fibroblasts and mouse Y-1 adrenal cells are not affected by 
toxin treatment (Cortes-Bratti et al., 1999; Johnson and Lior, 1988). CDT is a 
holotoxin complex, which comprises of three polypeptide subunits encoded by the 
adjacent linked genes cdtA, cdtB, and cdtC (Smith and Bayles, 2006). The entire 
complex is required to show a maximal activity (Heywood et al., 2005). It has 
been documented that CdtA, CdtB, or CdtC have no toxic activity when applied to 
cells separately, but when these three proteins are combined, they interact 
together to form an active tripartite holotoxin which produces maximum cell 
toxicity (Lara-Tejero and Galan, 2000). How CDT causes pathogenesis in C. jejuni 
is still unclear, but the mechanism of action is known. The toxic component CdtB 
(Lara-Tejero and Galán, 2001) shows activity similar to the enzyme 
deoxyribonuclease (DNaseI) (Lara-Tejero and Galan, 2000) which causes cell 
cycle arrest in the G2/M transition phase through blocking of CDC2 kinase, an 
enzyme known to be involved in mitosis entry (Pickett and Whitehouse, 1999). 
The entry of CdtB in the nucleus, which depends on an atypical nuclear 
localization signal, is important for the cytotoxic activity (McSweeney and Dreyfus, 
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2004). It was observed that CDT acts as nuclease and cuts the double-stranded 
DNA of host cells (Hassane et al., 2001). 
 
Incubation of HeLa cells with lysates from cdtB-deficient C. jejuni strains 81-176 
and NCTC 11168 showed that the NCTC 11168 lysate was greatly attenuated, 
while 81-176 lysates retained toxic activity, suggesting CDT to be the principal, but 
not the only toxin of C. jejuni (Purdy et al., 2000). It was also observed that C. 
jejuni mutants lacking CDT are possessing the competence to colonize NF-kB-
deficient mice, but are unable to cause gastroenteritis as it was observed for the 
wild type (Fox et al., 2004). Similar studies were also performed in Helicobacter 
hepaticus, where CDT mutants are showing the same results regarding to the 
colonization of the mouse gut (Young et al., 2004). 
 
1.2.5  Translocation 
Translocation is defined as the ability of bacteria to translocate from the 
gastrointestinal tract (GIT) to other internal organs (Berg, 1983). The competence 
to translocate across the cell barrier greatly differs among different pathogens. For 
instance, S. Typhi is able to migrate across a polarized monolayer which leads to 
cellular destruction and a complete loss of the monolayer integrity, whereas S. 
typhimurium causes significant less damage in the initial stage of the infection 
process (Kops et al., 1996). In order to infect the host, C. jejuni must cross the 
mechanical and immunological barriers of the GIT. In most organisms, the mucus 
membrane serves as the first line of defense which is 30 to 50 µm thick and is 
considered to be the first point of contact between the host cell and C. jejuni 
(Rozee et al., 1982). However, C. jejuni utilizes several virulence factors such as 
motility, adhesion, as well as capsule synthesis to penetrate these barriers 
(McSweegan and Walker, 1986). In addition, translocation was also observed in a 
few strains of C. jejuni across an intact polarized Caco-2 cell monolayer (Everes 
et al., 1992). The exact mechanism by which C. jejuni translocates across 
polarized cells is still unclear, however, electron microscopic studies suggested 
that both, transcellular and paracellular routes exist to cross polarized epithelial 
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cells (Konkel et al., 1992a). Translocation also occurs by disruption of the tight 
junction of adjacent cells which was achieved by disturbing the cellular 
cytoskeleton or by altering the specific proteins of tight junctions which are 
claudins, occludin, and junctional adhesion molecules (Schneeberger and Lynch, 
2004; MacCallum et al., 2005). Recently, it was also observed that Campylobacter 
induces translocation of non-invasive gastrointestinal bacteria (Lisa et al., 2009). 
The migration of Campylobacter spp. to the mesenteric lymph nodes is important 
for the pathogenesis of enteric infections which was observed in C3H or athymic 
and euthymic BALB/c germfree mice (Levine et al., 1983; FauchEre et al., 1985; 
Yrios and Balish, 1986). 
 
Translocation is inhibited by chloramphenicol, which indicates that this process is 
linked to active bacteria (Konkel et al., 1992a). In addition, it was observed that 
butyrate, which is an bacterial metabolite found in the lumen of the large intestine 
protects Caco-2 monolayers from C. jejuni infection (Rechkemmer et al., 1988; 
Von et. al., 2008)  
 
1.3  Response to stress 
Campylobacter species lack many adaptive responses as compared to other 
food-borne pathogens and therefore are more prone to environmental stress. The 
genomic study of C. jejuni might be a sound tool to insight into pathogenicity, 
growth and survival mechanisms under different stressful conditions (Tauxe et al., 
1992). Many studies have been attempted to focus on the involved mechanisms 
of C. jejuni survival at thermal stress i.e. above 42 0C. Konkel and coworkers 
(1998) have found that at least twenty four proteins were upregulated when heat 
shocked was provided to the cell in the temperature range from 43 0C to 48 0C. 
Under normal environmental conditions, some proteins behave as chaperones to 
ensure proper protein folding and also help to eliminate misfolded proteins 
(Konkel et al., 1998). Seventeen proteins that are either heat shock or chaperone 
homologues have been investigated in C. jejuni (Stintzi, 2003). Among these heat-
shock proteins, some were molecular chaperones including GroELS, DnaJ and 
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DnaK (Murphy et al., 2006). DnaJ has been further characterized by Konkel et al., 
(1998). Thereby, it has been established that the growth of DnaJ mutants was 
drastically reduced when incubated at 46 0C. Furthermore, they have lost the 
ability to colonize chicken cells, which documents the fact that heat shock proteins 
have a key role in both, thermotolerance and colonization. Most prokaryotes 
possess two-component regulators, which act as a survival mechanism by 
affecting gene expression in response to an environmental change (Murphy et al., 
2006). They are constituted by a cytoplasmic sensory histidine kinase and a 
response regulator in the cytoplasmic membrane.  
 
There are nine response regulators and six histidine kinases that have been 
reported in C. jejuni (Murphy et al., 2006). A signal transduction system called 
RacR–RacS was described by Bras and coworkers (1999). To define temperature 
as the function of the two-component regulator, C. jejuni mutants were generated 
that do not produce RacR. RacR mutant bacterial cells show a growth rate as the 
normal strain at 37 0C, but have declined growth at 42 0C. The study concluded 
that RacR has a temperature-dependent influence on the growth rate. It has been 
demonstrated that C. jejuni cells in a stationary phase are less prone to heat 
stress as compared to the exponential-growth phase, suggesting that 
thermotolerance is not responsible by changes accompanying stationary phase 
entry (Kelly, 2001). This finding is further supported by the lack of the rpoS gene in 
the genome of C. jejuni (Parkhill et al., 2000). 
 
The pH-value is also a determining factor of bacterial growth. The optimum pH for 
C. jejuni growth and survival is in the range between 6.5 and 7.5, with a maximum 
pH tolerance of about 9.0 (Chaveerach et al., 2003). C. jejuni cell numbers are 
significantly reduced when the pH is in a range above 9.0 or below 4.0 
(Chaveerach et al., 2003). The survival and infectivity of C. jejuni depends how 
rapidly it adapts to the acidic environment in the gastrointestinal tract of the host 
(Reid et al., 2008). However, the mechanism of how C. jejuni responds to low pH-
values has not been well documented. C. jejuni strain CI120 has an adaptive 
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tolerance response (ATR) for survival in the acidic environment that is induced by 
acid and oxygen (Reid et al., 2008). Protein synthesis is essential to augment 
ATR, indicating that pH-stimulating proteins are involved (Reid et al., 2008). 
However, a particular protein of C. jejuni responsible for protection against low pH 
has yet to be determined. (Reid et al., 2008, Ma et al., 2009). 
 
Campylobacter spp. is less tolerant to a sudden change in solute concentrations 
(osmotic stress) than other food-borne pathogens (Doyle and Roman, 1982). Birk 
and coworkers (2004) used chicken juice to study C. jejuni survival at different 
sodium chloride concentrations. They reported that C. jejuni strains incubated at 
42 0C were unable to grow in the presence of 2.0% sodium chloride. In addition, 
Campylobacter uses aerotaxis and chemotaxis as a defense mechanism to fight 
against various environmental responses (Hazeleger et al., 1998). 
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Objective of the study 
 
Campylobacter jejuni has emerged as an important food-born gastrointestinal 
pathogen for the last few decades in developing and industrialized countries. 
Furthermore, post infectious manifestations e.g. reactive arthritis or Guillain-barre 
syndrome might occur. In Germany approximately sixty thousand cases of 
Campylobacter mediated enteritis are reported annually. Although, a few factors 
that are essential for our understanding of the pathogenesis have been described, 
the mechanism of Campylobacter infection in humans is still not fully understood.  
 
In order to identify pathogenesis-related genes that have not been described so 
far, an existing transposon-generated mutant library of Campylobacter jejuni 
should be screened to detect mutants with reduced capacity to invade host cells. 
Corresponding genes, identified by this method, should furthermore be 
characterized with regard to their biological function to explain the particular effect 
of these genes during the procedure of host cell infection. For this, specific assays 
to answer the question which step in the complicated process of attachment, entry 
and maintenance of intracellular survival is affected by these new virulence 
associated factors will be performed. Taken together, this study is expected to 
give new insights in Campylobacter pathogenesis by the identification and 
characterization of to date unfamiliar infection-related factors. 
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2  MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Instruments 
Instrument Model and Manufacturer 
Agarose gel electrophoresis cells  Keutz Labortechnik, Reiskirchen 
Bio safety cabin     BDK and Luft Reinraumtechnik,  
Gmbh 
Balances       BP 221 S, Sartorius, Göttingen 
       LP6200 S, Sartorius, Göttingen 
Cell culture microscope     Modell DM IL, Leica, Heidelberg 
Centrifuges      Megafuge 2.0 RS, Heraeus, Hanau 
       Megafuge 2.0, Heraeus, Hanau 
       Modell 5417 R, Eppendorf, Hamburg 
       Modell 5417 C, Eppendorf, Hamburg 
       RC-26 Plus, Sorvall-Kendro, Hanau 
Electro Cell Manipulator    BTX ECM600, San Deigo, California 
Incubators      Heraeus, Hanau 
Gel documentation system    BioDoc II, Biometra, Göttingen 
Gel electrophoresis cells for PAGE Modell  Mini Protean II, BioRad, München 
Lightcycler 1.5     Roche, Basel, Schweiz 
Magnet bars      RCT basic, IKA Labortechnik,  
       Staufen 
pH-Meter       Modell 766 Calimatic, Knick, Berlin 
Power supply      EPS 600, Pharmacia Biotech 
Freiburg Standard Power Pack P25, 
Biometra,Göttigen 
Pipet aid       Hirschmann Laborgeräte, Eberstadt 
Pipettes       Modell Research, Eppendorf, 
Hamburg 
 
16 
 
Photometer      Ultraspec 1000, Pharmacia Biotech, 
Freiburg 
Shaking Incubater     SM-30 Control, Johanna Otto GmbH,  
Thermomixer      Modell Compact, Eppendorf,  
       Hamburg 
Thermocycler     Modell T3, Biometra, Göttingen 
UV-Crosslinker      UVC-500, Hoefer, San Francisco,  
       CA, USA 
UV-Table       TFX-20M, Gibco BRL, Eggenstein 
Water bath     Laborte Chink, Hannover Vinnhorst 
NanoDrop ND 1000 spectrophotometer Peqlab, Erlangen 
 
2.1.2 Cell culture media and additives 
2.1.2.1 Antibiotics (disc)  
Ampicillin      Oxoid Hampshire, England 
Kanamycin      Oxoid Hampshire, England 
Tetracycline      Oxoid Hampshire, England 
Ciprofloxacin      Oxoid Hampshire, England 
Gentamicin     Oxoid Hampshire, England 
Chloramphenicol     Oxoid Hampshire, England 
 
2.1.2.2 Antibiotics (powder) 
Chloramphenicol      Sigma Steinheim Germany 
Kanamycin      Sigma  Steinheim Germany 
Penicillin       Sigma Steinheim Germany 
 
2.1.2.3 Media and additives 
Dulbecco’s MEM (DMEM) Medium supplemented with 580 mg/l L–glutamine und 
3.7 g/l NaHCO3. 
DMEM Medium (10x) with 4.5 g/l D-glucose, 8 mg/l Phenol Red, without NaHCO3, 
Na-pyruvate and L-glutamine.  
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Penicillin / Streptomycin, 10,000 U / 10,000 µg/ml. 
Fetal Calf Serum (FCS); heat inactivated by incubation for 45 min at 56 0C. 
EDTA (Versen) 1% in PBS without Ca 2+, Mg2+ 
Trypsin (1:250) 0.25% in PBS without Ca2+, Mg2+ 
PBS (phosphate buffered saline) 
All the product mentioned above were obtain from Biochrom, Berlin 
 
2.1.2.4 Disposable materials and plastic ware 
Disposable materials and plasticware used in the cell culture were purchased 
from Nunc,  
 
Roskilde, Denmark; Falcon, Becton – Dickinson, Heidelberg; Corning Costar, 
Bodenheim; Greiner, Frickenhausen; Braun, Braun-Melsungen, Melsungen. 
 
2.1.2.5 Cell lines  
Human colon carcinoma Caco2 
 
2.1.2.6 Bacterial strains and mutants  
Bacterial Strains  Specification  Source  
Campylobacter jejuni  NCTC11168  
81-176  
B2  
 
Dr. A. Karlyshev  
Prof. M. Kist, Freiburg  
University Medical Center, 
Göttingen  
E. coli 
 
Transposone-generated mutants  
Library 
DH5α  
BL21 
B2 mutants 
Invitrogen  
CodonPlus-RIL Stratagene  
Dr. J. I. Dasti, Gottingen 
Institute of Medical. 
Microbiology 
2.1.2.7 Bacterial culture media 
Luria Bertani (LB) Broth   1% Bacto-Trypton 
       0.5% Bacto-yeast extract 
       0.5% NaCl  
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LB-Plates      0.5% Bacto-yeast extract 
        0.1% Bacto-Trypton 
       0.5% NaCl  
       1.5% Agar (Difco, Detroit, USA) 
Brain Heart Infusion    BactoTM 
Columbia Agar Base    Merck, Darmstadt 
Muller Hinton Agar    Oxoid, Wesel 
Sheep Blood      Oxoid Wesel 
 
2.1.3 Chemicals and reagents 
Chemicals and solutions were purchased from Roche (Mannheim), Merck 
(Darmstadt), Roth (Karlsruhe), Calbiochem (Bad Soden) or Sigma (Deisenhofen). 
In general, solutions were prepared using double distilled water. 
 
2.1.3.1 Antibodies 
Monoclonal Mouse anti His Tag primary antibody (Qiagen) Hilden  
Horseradish-Peroxidase-Conjugated anti Mouse secondary antibody (Dianova) 
 
2.1.3.2 Membranes and filters 
Nitrocellulose membrane    Hybond N (Amersham Biosciences) 
Nylon membrane     Hybond P (Amersham Biosciences). 
Filter discs     Oxoid, Wesel 
Corning 26 mm Syringe Filter, 0.20 µm Micron Membrane, 0.45 µm Micron 
Membrane 
 
2.1.3.3 Enzymes 
Quick T4 DNA Ligase     New England Biolabs 
Proteinase K      Roth, Karlsruhe 
Pfu DNA-Polymerase     Promega, Mannheim 
Taq DNA-Polymerase     Roche, Mannheim 
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Restriction endonucleases    New England Biolabs  
Alkaline antarctic Phosphatase   New England Biolabs 
KOD DNA-Polymerase    Novagen 
RNase A      Sigma-Aldrich, Steinheim  
DNase 1      Sigma-Aldrich, Steinheim 
RQI Rnase Free DNA    Promega, Mannheim 
 
2.1.3.4 Standard Buffers 
Alkaline Phosphatase (AP) staining solution 0.05% (v/v) BCIP 
       0.5% (v/v) NBT 
BCIP      5% (w/v) 5-bromo-4-chloro-3-indolyl-
       phosphate in ddH2O 
Blocking solution     5% (w/v) dry skimmed milk power 
       0.2% (v/v) Tween 20 
       0.2% (w/v) NaN3 
       in 1x PBS (pH 7.4) 
Coomassie staining solution   0.025% (w/v) Coomassie brilliant  
       blue G 
       30% (v/v) methanol 
       10% (v/v) acetic acid 
       in ddH2O 
Destaining solution    30% (v/v) methanol 
       10% (v/v) acetic acid 
       in ddH2O 
10x DNA loading dye    40% (v/v) glycerol 
       1% (w/v) bromophenol blue 
       in TE buffer (pH 8.0) 
NBT      1%(w/v) nitotetrazolium blue chloride  
       in ddH2O 
Separating gel (12%)          0.940 ml 2 M Tris-HCl (pH 8.8) 
       0.1 ml 10% (w/v) SDS 
20 
 
       1.94 ml 30% acrylamide  
       0.02 ml10% (w/v) APS 
       0.01ml TEMED 
        2.0 ml ddH2O 
Stocking gel (4.4%)    0.625 ml 0.5 M Tris-HCl (pH 6.8) 
       0.05 ml 10% (w/v) SDS 
       0.36 ml 30% acrylamide/ 
       0,125 ml 10% (w/v) APS 
       0.01ml TEMED 
       0.01 ml Bromphenol Blue 
       in ddH2O 
2x Sample buffer     20 % (v/v) glycerol 
       1 % (w/v) SDS 
       125 mM Tris-HCl (pH 6.8) 
       0.002 % (w/v) bromophenol blue 
       65 mM DTT 
       in 10 ml ddH2O 
Substrate solution  200 ml 10% (v/v) diethamolamine  
  (pH 9.6) 
       20 ul 5 mM MgCl2 
       800 ml physiological NaCl (pH 7.4) 
50x TAE (pH 8.0)     242 g Tris 
       57.1 ml 98% acetic acid 
       100 ml 0.5 M EDTA (pH 8.0) 
       in 1 L ddH2O 
10x TE buffer (pH 8.0)    100mM Tris 
       100 mM EDTA 
       in ddH2O 
Washing solution     0.05% (v/v) Tween 20 
       in 1xTBS (pH7.4) 
1% Triton X-100/PBS    1% (v/v) Triton X-100 
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       in 1x PBS 
TFB1 (pH 5.8)     100 mM RbCl 
       50 mM MnCl2 
       30 mM KAc 
       10 mM CaCl2 
       15% (v/v) glycerol 
       in ddH2O 
TFB2 (pH 6.8)     10 mM MOPS 
       10 mM RbCl
 
       75 mM CaCl2 
       15% (v/v) glycerol 
       in ddH2O 
 
2.1.3.5 Kits and reagents 
 
RNA Isolation 
Ribo-Pure Bacteria Kit      Ambion 
 
Reverse Transcription 
One Step RT-PCR Kit    Qiagen, Hilden 
 
DNA Cloning Kit 
QIAGEN PCR Cloning Kit    Qiagen, Hilden 
 
Plasmid-DNA Isolation 
GenElute Plasmid Mini Prep Kit   Sigma-Aldrich, Deisenhofen 
 
DNA Isolation from Agarose Gels 
QIAEX II Gel Extraction Kit    Qiagen, Hilden 
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DNA and PCR Purification 
QIAquick PCR Purification Kit    Qiagen, Hilden 
 
Genomic DNA Isolation 
QIAamp. DNA Mini Kit    Qiagen, Hilden 
 
Protein-His Tag Expression and Purification 
QIAexpress Kit     Qiagen, Hilden 
 
Quantification of Proteins 
Pierce BCA Protein Assay Kit   Pierce, Rockford, IL, USA 
 
Molecular weight markers 
GeneRuler 100 bp DNA Ladder  MBI Fermentas 
GeneRuler 1kb DNA Ladder   MBI Fermentas 
Prestained Protein Marker, Broad Range New England Biolabs 
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2.1.3.6  Oligonucleotide 
Table 2.1 HPLC-purified oligonucleotide primers used for sequencing 
Gene  Primer name Sequence (5’ to 3’) 
 
aphA-3 
 
KanF 
 
TATCACCTCAAATGGTTCGCT 
cj0952c-51c Cj0952c-51cF GCCAATTCATTTTCATTTTGAGA 
 Cj0952c-51cR TTTTAATGCTTAAAGTTGTTGTTGG 
 
Table 2.2 HPLC-purified oligonucleotide primers used for cloning in pRRC and pBluescript II  
Gene  Primer name Sequence (5’ to 3’) 
   
 
cj0952c Cj0952cF GCTCTAGATAGGAAACTATGATGTTTAAAACTA 
 Cj0952cR GCTCTAGAAATTAATTGATATATCCACA 
cj0952c/ Cj0952cF GCTCTAGATAGGAAACTATGATGTTTAAAACTA 
cj0951c Cj0951cR NNNTCTAGACCTTTAAATTTGAAATTGGTTAAGTTCGC 
cj0952c/ Cj0952cF GCTCTAGATAGGAAACTATGATGTTTAAAACTA 
cj0951cHis Cj0951His GGCTCTAGATTAGTGATGGTGATGGTGATGAATTTG 
AAATTGGTTAAGTTCGC 
cj0952c/ Cj0952F GCTCTAGATAGGAAACTATGATGTTTAAAACTA 
cj0950c Cj0950R NNNTCTAGAGGGCATTATTTAAAAAAGATTTTGATTTC 
cj0005c Cj00005cF GCTCTAGATTAAGGATATTTCAATGAAACAGAAC 
 Cj00005cR GCTCTAGAACTTAAACTCCATAAACATTAACTC 
kanR Kan1 P-GTAAGATTATACCGAGGTATGAAAACG 
 Kan2 P-AATCTAGGTACTAAAACAATTCATCCA 
 
 
XbaI restriction sites for cloning in pRRC and pBluescript II are underlined, the 
start codon of cj0952c and cj0005c are shown in bold and the putative SD 
sequence is illustrated in italic. Primers Kan1 and Kan2 are 5’-phosphorylated. 
Gene numbering according to C. jejuni strain NCTC 11168. 
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Table 2.3 Oligonucleotide primers used for semiquantitative real-time RT-PCR analysis 
 
Gene Primer name Sequence (5’ to 3’) 
23S Cj23SF GTTCGCCATTTAAAGCGGTA 
 Cj23SR TGCTCTTGGCAGAACAACAG 
cj0951c Cj0951fF GAGTTACCAAAGCCCTAGCATC 
 Cj0951R CATGGTCAATCAAGCAGG 
cj0952c Cj0952F GCCACTTCCTTGAGC 
 Cj0952R CGCCCTTTGATTGCAGATG 
cj0953c Cj0953F GGCTGAAATGATTACTTCTAC 
 Cj0953R CTAACCGATATTAACGCAGC 
groEL (cj1221) GroELF ATGGGGCCAAGAGGACGCAA 
 GroELR GCAGTAGTTGTTCCATCGCCTGCT 
dnaJ (cj1260c) DnaJF GGCTTTGGCTCATCGCGTCG 
 DnaJR ACCTTGAGAAACCCCAACCTGTCC 
dnaK (cj0759) DnaKF TGCTGTGTATGAACGCGGCGA 
 DnaKR ACCGCTTGGCGTTTTGCACT 
cheY (cj1118c) CheYF GCTGAGCATGGCGTTGAAGC 
 CheYR ACTCCAAGCCATTCATTTCTGGCA 
tlp7 (cj0952c) Tlp7F GAGTTACCAAAGCCCTAGCATC 
 Tlp7R CATGGTCAATCAAGCAGG 
cadF (cj1478c) CadFF TGGACATTATGGCGCGGGTGT 
 CadFR TGTGGAGTTGCACGAGTATCAGCA 
peb1a (cj0921c) Peb1aF ACAAGAGGCCCTTTGCTTGATAATGGT 
 Peb1aR AGTTGCAGCTTGAGCCACTCCA 
jlpA (cj0983) JlpAF AGCACACAGGGAATCGACAGCA 
 JlpAR AAATGACGCTCCGCCCATTAACA 
ciaB (cj0914c) CiaBF TCATGCGGTGGCATTAGAATGGG 
 CiaBR CATCATTTGGAACGACTTGAGCTGAGA 
cdtB (cj0078c) CdtBF TGCAAGGCTCATCCGCAGCC 
 CdtBR TGGCGTCCTGTTGGAGTGGC 
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flaA (cj1339c) FlaAF AGGCGCTATGGCTGTGATGGA 
 FlaAR TGCACTCTCGGCTGCAAAGTCT 
ptmC (cj1327) PtmCF ACAGGCATGGAAATTTAGGCGA 
 PtmCR ACAAGCTCCCAAGGCAACCGC 
ptmD (cj1328) PtmDF ACCAAAGCAAATGCCGATGAAAATGG 
 PtmDR AACGCCCTTTTTGTCTATCGCCT 
ptmE (cj1329) PtmEF ACTAGGTACAGCAGGGGCTTTAAGC 
 PtmER CTCACGCACGCAAACGCTCA 
ptmF (cj1330) PtmFF GCTAGGTGGTGGGGTTTTACTCGA 
 PtmFR GCCAAAAAGGCAAAATCATCGCTTGT 
ptmB (cj1331) PtmBF GCTAGGGGTGGTAGCAAAGGCG 
 PtmBR GCAAGGCATCACGCATGACAGGA 
ptmA (cj1332) PtmAF CGCGTTAATACTCTAGCAAGCGGAGG 
 PtmAR AAGCCCCATCCATCATCTACCACT 
pseD (cj1333) PseDF CCCATGGCAATGATCCTCTTGATGC 
 PseDR TCCAAAGAAAGCACATAATCGGGCT 
pseE (cj1337) PseEF TGTTGGAACGCGATGAAATAGTAGCT 
 PseER GCATCTCGCAAAAGGCTGGCC 
pseB (cj1293) PseBF CGGGCGGAACAGGCTCGTTT 
 PseBR CGTCGATGACATTTTGCGCACCG 
pseC (cj1294) PseCF GCCGCTACAGCTAATGCGGC 
 PseCR GCTGGTTTATCCCTAAAGCACAAGCA 
pglE (cj1121c) PglEF AGGAGCTATTGGCGTAGCGCA 
 PglER TCATCGCCGTGCCACTTGC 
pseA (cj1316) PseAF ATGGCGGTCCTGCGAGTAGT 
 PseAR TGCTCTAACCAAAGCCGTATTTGCA 
porA (cj1259) PorAF TGGCTGCAGAGCAAGGTGCA 
 PorAR AACCTACAGCAGCAGCACCG 
flap (cj1279c) FlpAF GGTTCTGAACGAAGCCCGGCT 
 FlpAR AGACGCTATGGCGGGGGAGCA 
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ptmG (cj1324) PtmGF TGTGATCACTGCGGTGATGCCAA 
 PtmGR ACCTCCACTTACGGCAATAGCACA 
ptmH (cj1325) PtmHF TGGCAATGGTGTACATTCAGCG 
 PtmHR TCCACCTGTGTTCAAAAGTTCGT 
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2.2 Methods 
 
2.2.1 Cell Culture 
2.2.1.1 Bacterial strains and culture conditions  
The Campylobacter jejuni strains used in this study were B2, isolated in the 
University Medical Center Göttingen from a patient suffering from gastroenteritis 
(Schmidt-Ott et al., 2005; Dasti et al., 2007), NCTC 11168 and strain 81-176. All 
strains were cultured on Columbia blood agar supplemented with 5 % defibrinated 
sheep blood under microaerophilic conditions (85 % N2, 10 % CO2, and 5 % O2) 
at 42 0C for 24 hours. As per requirement, appropriate antibiotics were added at 
the following concentrations: kanamycin (50 µg/ml) or chloramphenicol (30 µg/ml). 
For growth experiments, bacteria were grown at 42 0C in MH broth under 
microaerophilic conditions in the presence or absence of 10 mM formic acid or 10 
mM Na2SO3. Every growth experiment was carried out three times. Escherichia 
coli strain DH5α which was used for cloning experiments was grown on Luria-
Bertani (LB) agar or in Luria-Bertani broth at 37 0C. When necessary, the medium 
was supplemented with ampicillin (100 µg/ml). 
 
2.2.1.2 Preparation of chemical competent E.coli cells 
A single colony of E.coli DH5α was inoculated into 10 ml of LB broth and kept 
overnight at 37 0C under shaking. 2 ml of the over night culture was added into 
100 ml of pre-warmed LB broth and left on the shaker until an OD(600nm) of 0.5 was 
reached. The culture was transferred into a 50 ml Falcon tube and cooled on ice 
for 10 min. Cells were centrifugated at 4000 x g for 10 min at 4 0C in a pre-cooled 
centrifuge. Then the cell pellet was gently resuspended in 30 ml ice cold TFB1 
buffer and incubated on ice for 30 min. Cells were pelleted by centrifugation as 
described above, resuspended in 2 ml ice-cold TFB2 buffer and incubated on ice 
for another 30 min. After incubation aliquots of 100 µl were stored at -80 0C.  
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2.2.1.3 Generation of electrocompetent bacterial cells   
10 ml of LB-broth were inoculated with a single E. coli DH5α colony and incubated 
overnight at 37 0C under shaking. Afterward, three ml of the overnight culture 
were grown in 500 ml LB-broth at 37 0C until an OD(600nm) of 0.35-0.45 was 
reached. After placing the culture on ice for 10 min it was centrifuged for 15 min at 
4,000 × g at 4 0C. The pellet was gently resuspended in 50 ml cold water and 
again centrifuged for 15 min at 4,000 × g. After repeating this step three times, the 
cell pellet was resuspended in 15 ml 10 % glycerol and centrifuged again. Finally, 
the cell pellet was carefully dissolved in a final volume of 1 ml 10 % glycerol and 
100 µl aliquots were used for each electroporation. In order to prepare competent 
cells of C. jejuni, cells were collected from Columbia blood agar plates and 
centrifuged at 5,000 × g at 4 0C for 10 min. The cells so obtained were 
resuspended in 1 ml ice-cold washing buffer containing 272 mM sucrose and 15 
% glycerol at 4 0C. After repeating this step three times, the pellet was re-
suspended in 400 µl washing buffer and 100 µl aliquots were used for each 
transformation. 
 
2.2.1.4 Electroporation 
After the addition of 0.5 to 3 µg of plasmid DNA to the electrocompetent cells, the 
mixture was transferred into an ice-cold electroporation cuvette and the cuvette 
was incubated on ice for 30 sec. Electroporation was performed at 2.5 kV, 25 µF 
and 200 Ω using a BTX Electro Cell Manipulator. Then, 500 µl of SOC medium 
was added to the cuvette and in case of C. jejuni the suspension was transferred 
onto a non selective Columbia blood agar plates and incubated overnight at 37 0C 
under microaerophilic conditions. Finally, the cells were transferred onto selective 
plates and incubated at 42 0C under microaerophilic conditions for further 2-3 
days. After electroporation of E.coli cells, the suspension was transferred to a 
polypropylene tube, incubated with gentle rotation for 1 hour at 37 0C and plated 
on LB agar containing the appropriate antibiotic. 
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2.2.1.5 Cultivation of eukaryotic cells 
Human colon carcinoma 2 (Caco2) cells were maintained in 175 cm2 and 25 cm2 
cell culture flasks as well as in 6 well plates in Dulbecco minimal essential 
medium (DMEM) supplemented with 10 % heat inactivated fetal calf serum, 1x 
non-essential amino acids, with/without 100 U/ml penicillin, and 100 µg/ml 
streptomycin. The cells were routinely cultured in a humidified atmosphere of 95 
% air and 5 % CO2 at 37 0C. The Caco2 cells were grown in 175 cm2 flask to form 
a confluent monolayer for 2 days. Afterwards, the cells were split by removing the 
old media, washing the monolayer with 5 ml EDTA and detaching the cells with 5 
ml of trypsin. Then 10 ml of DMEM medium (10 % FCS and 1x non-essential 
amino acids) were added, the cells were centrifugated at 1380 rpm for 5 min. and 
recultivated in 175 cm2 cell culture flasks (10 % FCS, 1 % NEAA, 1 % 
Penicillin/streptomycin).  
 
2.2.1.6 Invasion and adhesion assays 
Bacterial invasion of host cells was initially described by Everest et al., (1992). 
After achieving a semiconfluent layer cells were washed with PBS and 400µl C. 
jejuni suspension in DMEM, (10 % FCS and 1x NEAA) were added. To assure 
that the number of bacteria was identical in every assay performed, the solution 
was adjusted to an OD(600nm) of 0.5 representing a multiplicity of infection (MOI) of 
100 and incubated at 37 0C, 5 % CO2 to allow the bacteria to invade the host cell. 
In some experiments bacteria were brought in contact with the Caco2 cell by 
centrifugation on 6 well plates at 600 x g for 15 minutes. At 2 hrs post infection, 
the cells were washed three times with 1x PBS before further incubation with 
culture medium containing 100 µg/ml gentamicin. After treatment with gentamicin 
for 2 hrs the cells were washed again three times with 1x PBS. Then the cells 
were lysed with 1 % Triton X-100 for 10 min to release intracellular bacteria. 
Finally, the number of viable bacteria was determined by plating serial dilutions on 
Columbia blood agar and counting of the number of bacteria grown after 
incubation for 48 hrs at 42 0C under microaerophilic conditions. Thereby, the 
number of colonies obtained after the invasion assay with wild-type strain B2, 
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mutants and complemented mutants was defined as cfu in each experiment.  In 
order to investigate bacterial adhesion, Caco2 cells were incubated with the 
bacteria for only 30 min. After the monolayer was washed with PBS, the cells 
were lysed and the bacteria were plated on Columbia blood agar plates in order to 
determine the number of recovered bacteria as described above.  
 
2.2.1.7 Freezing and thawing of Caco2 cells 
The detached Caco2 cells were suspended in 40 % DMEM and mixed with the 
same volume of 2x freezing solution (20 % DMSO, 40 % FCS in DMEM). One 
mililiter aliquotes were kept for one day at -80 0C and transferred into liquid 
nitrogen for long term storage. In order to thaw the frozen cells, a cryotube was 
taken from liquid nitrogen and incubated in a 37 0C water bath. After the cells were 
thawed they were cultured under the conditions described above. 
 
2.2.2 Modification of nucleic acids 
 
2.2.2.1 Preparation of genomic DNA 
Genomic DNA of C. jejuni was isolated using the QIAamp DNA Mini Kit following 
the manufacturer’s instructions. The bacteria were removed from culture plates 
and mixed with 180 µl of Buffer ATL by vigorous shirring. Then 20 µl of Proteinase 
K was added and the sample was incubated at 56 0C until the bacteria were 
completely lysed. After lysis 200 µl of AL buffer was added and the sample was 
incubated at 70 0C for 10 min. After mixing 200 µl of ethanol (100 %) to the 
sample the lysate was transferred to a QIAamp spin column and centrifuged at 
6,000 g for 1 minute. The column was washed once with 500 µl of buffer AW1 and 
then with 500 µl buffer AW2. Finally, the QIAamp spin column was transferred in a 
clean 1.5 ml tube and the genomic DNA was eluted with 200 µl Buffer AE. 
 
2.2.2.2 Isolation of plasmid DNA 
Plasmid DNA was isolated from E. coli cells using a plasmid purification kit 
(Sigma-Aldrich) according to the manufacturer’s instructions. Bacteria from a 2 ml 
31 
 
of overnight culture were centrifugated and resuspented in 200 µl resuspension 
solution. Then 350 µl of neutralization solution was added and the sample was 
transferred to a spin column and centrifugated at maximum speed for 1 min. After 
washing the column with 750 µl washing solution, the plasmid DNA eluted with 10 
µl of the appropriate buffer. 
 
2.2.2.3 Isolation of RNA 
Bacterial RNA was extracted from C. jejuni cells with the RiboPure Bacter Kit 
(Ambion) following the recommendations of the protocol. After the over night 
culture was centrifugated, 350 µl RNAwiz solution was added and the sample was 
transferred to a tube containing 250 µl Zirconioa beads. After mixing for 10 min at 
maximum speed the sample was centrifugated for 5 min at 4 0C. The supernatant 
was transferred to a fresh 1.5 ml tube and mixed with 0.2 x volume of chloroform. 
Then the sample was centrifugated for 5 min at 4 0C and the aqueous phase was 
conveyed to a fresh 1.5 ml tube where 0.5 x volume of 100 % ethanol was added. 
The mixture was converted into filter cartilage for centrifugation at 13,000 rpm for 
1 min.  Afterwards the flow-through was discarded and the column was washed 
once with 700 µl wash solution 1 and twice with wash solution 2/3. Finally, the 
RNA was eluted by applying 30 µl of preheated (95 0C to 99 0C) elution solution to 
the centre of filter and centrifugation for 1 min. After RNA isolation, DNA 
contaminations were removed by DNase I treatment and incubation at 37 0C for 
30 min followed by denaturation of the enzyme by for 15 min at 75 0C. To make 
sure that the RNA was free of remaining traces of DNA after DNase I treatment, 
PCR assays were performed after every preparation. 
 
2.2.2.4 Quantification of DNA and RNA 
Concentrations of DNA and RNA were determined with a NanoDrop ND 1000 
spectrophotometer according to the instruction of the manufacturer.  
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2.2.2.5 Polymerase chain reaction (PCR) 
PCR was used to amplify C. jejuni genes for subsequent cloning into vectors 
pRRC or pBluescript II. The genomic DNA of wild type B2 and mutant were used 
as template to amplify the desired sequences, using PCR primers with or without 
introduced endonuclease restriction sites which are summarized in Table 2.2. 
Each 50 µl of PCR mixture contained 40 ng genomic DNA, 10 mM TRIS-HCl pH 
8.3, 50 mM KCl, 1.5 mM MgCl2, all four dNTPs (each 0.2 mM) and 2.5 U Taq DNA 
polymerase . After initial incubation at 95 0C for 1 min, 40 cycles at 95 0C for 30 s, 
55 0C for 30 s and 72 0C for 1 min were carried out with a final incubation at 72 0C 
for 10 min. Different annealing temperatures were used based on the melting 
point of the respective primer pairs, while the length of the amplified region 
determined the elongation time (30 s for each 1 kb). All PCR products were 
analysed on 1-1.5 % agarose gels stained with ethedium bromide at a final 
concentration of 1 µg/ml. The size of PCR products was determined by using the 
1 kb or 100 bp GeneRulers DNA ladder which was run along with the PCR 
sample. 
 
2.2.2.6 Conventional reverse transcriptase-PCR 
Conventional (RT)-PCR assays were carried out with the OneStep RT-PCR Kit 
following the manufacturer’s recommendations. After reverse transcription of 10 
ng for 30 min at 50 0C, 35 cycles of amplification were performed according to the 
following protocol: cDNA was denatured at 94 0C for 30 s, primer annealed at 55 
0C for 30 s and extended at 72 0C for 1 min, with a final incubation at 72 0C for 10 
min. The primers used for reverse transcriptase-PCR are listed in Table 2.3. 
 
2.2.2.7 Real-Time reverse transcriptase-PCR analysis 
Semi-quantitative real-time RT-PCR analysis was carried out with the LightCycler 
1.5 and the QuantiFast SYBR Green RT-PCR Kit. LightCycler PCR assays were 
performed in glass capillaries in triplicate in a final volume of 20 µl with 10 pmol of 
each HPLC purified primer, 10 µl of master mix and 50 ng. Amplicons of the 
constitutively transcribed 23S gene were applied to adjust the RNA samples under 
33 
 
investigation based on the crossing points obtained for this gene. 23S RT-PCR 
was carried out according to this protocol: initial reverse transcription for 20 min at 
50 0C and denaturation for 5 min at 95 0C was followed by 25 cycles of 
denaturation (95 0C; 10 s), annealing (50 0C; 10 s) and elongation (72 0C; 5 s). 
After adjustment of the RNA samples real time RT-PCR assays for the genes 
under investigation were run. Therefore, reverse transcription was followed by 25 
cycles of denaturation (95 0C, 10 s), annealing (55 0C; 10 s) and elongation (72 
0C; 10 s). Each PCR included a negative control comprising of all elements 
without RNA to monitor possible contamination. The primers used for both assays 
are listed in Table 2.3. Every assay was run in duplicate. The specifity of the signal 
was assured by melting curve analysis and agarose gel electrophoresis. Semi-
quantification of transcription levels were calculated as follows: x = 2∆Cp, where x 
represents the factor of altered transcription, and ∆Cp illustrates the difference of 
crossing points (Cp1-Cp2) of the two samples to be compared. 
 
2.2.2.8 Enzymatic digestion of DNA 
Purified PCR products harbouring the required endonuclease restriction sites and 
cloning vectors were digested by 10 U restriction endonuclease in such a way that 
10 µl of purified PCR product or 1 µg of cloning vector were incubated with 1x 
NEB buffer, 1x 10% BSA (optional) and dH2O in a volume of 20 µl at 37 0C for 2 
hrs. 
 
2.2.2.9 Purification of PCR products 
DNA extraction from agarose gels were performed using QIAGEN PCR 
Purification Kit according to manufacturer’s protocol. DNA fragment was excised 
with a scalpel from the agarose gel, weighted and three volume of buffer QG to 
one volume of excised gel was added, respectively. The mixture was completely 
dissolved by incubating at 50 0C for 10 min and mixed thoroughly with 1 gel 
volume of isoproponal. Then the sample was transferred to a QIAquick spin 
column placed in 2 ml collection tube, centrifugated 13,000 rpm for one min and 
washed with 750 µl of buffer PE. After all, the DNA was eluted by adding 30 µl of 
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elution buffer in the middle of column and final centrifugation at 8,000 rpm for 1 
min. 
 
2.2.2.10 Ligation 
The restricted DNA fragments were ligated to a vector in a final volume 20 µl 
containing 1:3 molar ratios of vector and insert, 1 µl of Quick T4 DNA ligase, 1x 
ligation buffer and ddH2O. The ligation reaction mixture was kept at room 
temperature for 1 hour or incubated over night at 16 0C. 
 
2.2.2.11 Direct sequencing of genomic DNA from C. jejuni 
Each 10 µg of genomic DNA were sequenced directly by the SeqLab Company 
(Göttingen, Germany) applying 10 pmol of KanF primer which is listed in Table 
2.1. 
 
2.2.3 Experiments related to mutants of C. jejuni and their characterization 
 
2.2.3.1 Knock-out inactivation of cj0005c 
Primers Cj0005cF and Cj0005cR (Table 2.2) were used to amplify a 1239 bp DNA 
fragment corresponding to C. jejuni gene cj0005c. The PCR fragment was XbaI-
digested and inserted into plasmid vector pBluescript II KS to obtain pBcj0005c. 
To insert a kanamycin resistance cassette containing the aphA-3 gene, PCR was 
carried out with plasmid pSB1699 as a template and the 5’-phosphorylated 
primers Kan1 and Kan2 (Table 2.2). The PCR reaction contained 10 mM Tris-HCl 
pH8.3, 50 mM KCl, 1.5 mM MgCl2, all four dNTPs (each 0.2 mM), 10 pmol of 
primers and 1 U Pfu Polymerase to generate a blunt-end PCR product. After initial 
incubation at 95 0C for 1 min, 30 cycles at 95 0C for 30 s, 55 0C for 30 s and 72 0C 
for 1 min followed, with a final incubation at 72 0C for 10 min. Following 
purification of the PCR product using the QIAquick PCR Purification Kit (Qiagen), 
the kanamycin resistance cassette was cloned into plasmid pBcj0005c, which was 
BsaB1 blunt end restricted and dephosphorylated with Antarctic Phosphatase 
(New England Biolabs) to obtain pBcj0005cKan.  
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2.2.3.2 Cloning of C. jejuni genes into expression vector pRRC 
The C. jejuni genes were PCR-amplified and subsequently cloned into expression 
vector pRRC using primers harboring restriction sites for XbaI, respectively. The 
primer sequences with XbaI restriction sites are mentioned in Table 2.2. The 
Campylobacter expression vector pRRC contains a Camr gene cassette which is 
bounded by a 16S sequence and tRNAs for alanine and isoleucine, respectively. 
Immediately downstream of the Camr gene cassette resides a single XbaI site to 
allow the expression of XbaI-cloned genes under the control of the constitutively 
expressed Camr gene promoter. After transformation of C. jejuni with the 
recombinant plasmid, the Camr gene cassette together with the XbaI-cloned gene 
is integrated into one of the 16S loci of the recipient cell via highly efficient double 
recombination (Karlyshev and Wren, 2005). 
 
2.2.3.3 Motility assay 
One microliter of an overnight culture of C. jejuni adjusted to an OD(600nm) of 0.025 
was sticked in the center of a 0.4 % Mueller-Hinton agar plate with the help of a 
suited normalized inoculation loop. Afterwards, the plates were incubated at 42 0C 
under microaerophilic conditions for 36 hrs. The low concentration of the agar 
allows the bacteria to swarm, and to form a visible halo within the agar. Motility of 
the bacteria under investigation was judged by the expansion of the halos which 
was examined by the measurement of the respective radii. Each experiment was 
performed seven times. 
 
2.2.3.4 Chemotaxis assay 
For chemotaxis assays, bacteria were grown on Columbia blood agar plates 
overnight at 42 0C under microaerophilic conditions. Then, the bacteria were 
suspended in PBS (pH 7.0), adjusted spectrophotometrically to an OD(600nm) of 1 
and mixed (1:1) with temperate soft agar (0.8 %, BD, Heidelberg, Germany). 
Afterwards, 12 ml of the bacterial soft agar suspension were poured into a petri 
dish and 6 mm discs sodden with 20 µl of the respective test chemicals (0.1 M 
and pH 7.0) were placed on the solidified agar. Zones of bacterial attraction or 
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repulsion were measured after four hours of incubation at 42 0C under 
microaerophilic conditions. The chemotaxis assays have been carried out four 
times, respectively. 
 
2.2.3.5 Autoagglutination assay 
Autoagglutination assays were performed as described by Misawa and Blaser 
(2000). Bacteria inoculation from petri dishes were suspended in PBS and 
adjusted to an OD(600) of approximately 1.0. Bacterial suspensions of 2 ml were 
incubated under a microaerophilic condition for 24 hrs at 37 0C. Then, 1 ml of the 
suspensions were removed carefully and the OD(600) was measured. Bacterial 
strains under investigation were measured five times. The obtain data were 
normalized following the protocol of Howards and co-workers (2009). 
 
2.2.4 Analysis of Protein Expression 
 
2.2.4.1 Measurement of protein concentration 
Protein concentrations were quantified by BCA protein assay kit (Pierce) 
according to the manufactures instructions. 
 
2.2.4.2 Sodium dodecyl sulphate polyarcylamide gel electrophoresis      
(SDS-PAGE) 
Proteins were separated by SDS-PAGE. The acrylamide gel cast was set up by 
laying two spacer sandwiched between rectangular glass plates. Firstly, the 
separating gel (10 % or 12 %) was applied to the space. After the polymerization 
of the separating gel, the stocking gel (4.4 %) was pipetted on the top of the 
separating gel and a comb was inserted into the sandwiched plates. After the gel 
was solidified, the comb was removed and the gel was ready to use. 
 
2.2.4.3 Protein analysis by SDS-PAGE 
The bacteria were suspended in 8 M urea and boiled for 10 min at 95 0C in order 
to lyse the cells. Equal amounts of cell lysates were mixed with 2 x SDS-PAGE 
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sample buffer and heated at 95 0C for 10 min before gelelectrophoretic 
separation. The SDS gel was run at 32 mV for approximately 2hrs. After 
electropheresis, gel was stained with Coomassie staining solution for 1 hour. 
Unspecific staining was removed by incubating the gel in 30 % methanol and 10 
% acetic acid. Finally, the Coomassie stained gel was sealed in cellophane and 
dried overnight. 
 
2.2.4.4 Purification of a 6xHis-tagged Protein from C. jejuni under denaturing   
conditions 
All steps were carried out according to the QIA expressionist protocol (Qiagen) 
with the solutions recommended for purification of 6x His-tagged proteins under 
denaturating conditions. The cell were suspended in lysis buffer (100 mM 
NaH2PO4, 8 M urea, 10 mM Tris-HCl, pH8.0) and stirred on a shaker for 60 min at 
room temperature. After centrifugation at 10,000 g the supernatant was mixed 
with Ni-NTA beads (1 ml Ni-NTA slurry to 4 ml cleared lysate) and gently mixed at 
200 rpm on a rotary shaker for 90 min at room temperature. Then the lysate Ni-
NTA was loaded carefully into an empty column and the flow through was 
collected. The column was washed twice with 4 ml buffer C (100 mM NaH2PO4, 
10 mM Tris-HCl, 8 M urea, pH 6.3) and the his-tagged protein was eluted with 
elution buffers D (100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, pH 5.9) and E 
(100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, pH 4.5) following the instruction of 
the manufacturer.  
 
2.2.4.5 Western blotting 
Proteins separated on 12 % SDS-PAGE were transferred to a PVDF membrane 
(GE Healthcare) using a semidry transport system (Sartorius). For this the blot 
sandwich was build up in the following arrangement. Anode (+): soaked 6 
Whatman filter papers in 0.3 M Tris-HCl, pH 10.4 and 20 % methanol, soaked 3 
Whatman filter papers in 25 mM Tris-HCl, pH 10.4 and 20 % methanol, 
nitrocellulose membrane gel, 9 Whatman filter papers soaked in 40 mM 6-
aminocapronic acid, pH 7.6 and 20% methanol, Cathode (-) . The proteins were 
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transferred at 0.9 mA /cm2 of gel size for 90 min. The membrane was blocked for 
1 h with 5 % milk powder in PBS containing 0.05 % Tween 20. After incubation of 
the membrane with a 1:3,000 diluted monoclonal mouse anti His primary antibody 
over night at 4 0C, the immune complexes were labelled with a 1:3000 diluted 
horseradish-peroxidase-conjugated anti mouse secondary antibody for 1 h at 
room temperature. The membrane was washed 4 x for 20 min with 0.05 % Tween 
20 and incubated with ECL reagent (GE Health Care). Finally the membrane was 
covered by plastic foil and visualized by ECL chemoluminiscence following the 
manufacturer’s recommendations. 
 
2.2.4.6 Statistical analysis 
Significant differences between mean values were calculated by the Student’s t-
Test using MS-Excel software. P-values of less than 0.01 were considered to be 
significant. 
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3 RESULTS 
 
3.1 Invasion capacity of C. jejuni isolate B2 and the C. jejuni strains NCTC 
11168 and 81-176 
Invasion experiments using Caco2 cells were performed in order to determine the 
infectivity of C. jejuni strain B2 compared to the well characterized C. jejuni strains 
NCTC 11168 and 81-176 by performing gentamicin protection assays. Thereby, it 
was observed that isolate B2 is more invasive than both reference strains. The 
result of this experiment is shown in Fig. 3.1. The mean value of colonies that 
were recovered from infections with the clinical isolate B2 was 1.2x106 cfu/ml, 
whereas 0.85x105 and 4.1x105 cfu/ml were counted for, NCTC 11168 and 81-176, 
respectively.  
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Figure. 3.1 Comparative analysis of the C. jejuni strains B2, NCTC 11168 and 81-176 
Invasion assays using Caco2 cells showed increased infectivity of clinical isolate B2. The mean 
values of colonies recovered from NCTC 11168 and 81-176 were 0.85x105 and 4.1x105 cfu/ml. 
Compared to these two reference strains, the infectivity of the clinical isolate B2 was clearly higher 
with 1.2x106 cfu/ml. 
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3.2 Identification of invasion related C. jejuni genes  
To identify candidate genes that mediate a less invasive activity of C. jejuni to 
invade Caco2 cells, altogether 660 clones of an existing transposon-based mutant 
library of the C. jejuni strain B2 which was kindly provided by Dr. J. I. Dasti, 
(University of Gottingen) were individually analysed by performing gentamicin 
protection assays. Out of these 660 clones, seven clones have been detected 
with a strongly decreased invasiveness (Fig 3.2). Direct genomic sequencing was 
applied in order to determine the transposon insertion site within the genome of 
the respective C. jejuni clones, using a primer that binds directly to the 5’ region of 
the kanamycin resistance cassette and, therefore, allows the determination of the 
affected C. jejuni genes. In order to approve the reduced invasiveness, 
gentamicin protection assays with the respective clones and wild-type strain B2 
were repeated five times. Thereby, the mean value of colonies recovered from 
clinical isolate B2 were 1.1x106 cfu/ml whereas the cfu/ml obtained for the 
respective mutants were as follows: cj0005c: 2,8x105 cfu/ml, cj0078c: 3.4x105 
cfu/ml, cj0093: 4.1x105 cfu/ml, cj0268c: 3.3x105 cfu/ml, cj0721c: 3.2x105 cfu/ml, 
cj1439c: 3x105 cfu/ml, and cj0952c: 2.3x105 cfu/ml with P-values of <0.001, 
respectively. The results are summarized in Fig. 3.2 and table 3.1. 
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Figure 3.2 Invasion of the B2 wild-type strain and selected clones of a transposon based 
mutant library 
The names of clones correspond to the mutated gene. See text for details. 
 
Table 3.1 Specification of the detected genes with regard to function and localization as far 
as known 
 
Gene Putative Function 
cj1439c UPD-galactopyranose mutase 
cj0952c N-terminal of a chemoreceptor 
cj0721c  Integral membrane protein 
cj0268c Transmembrane protein 
cj0093 Periplasmic protein 
cj0078c CdtB, cytolethal distending toxin 
cj0005c Sulphite:cytochrome c oxidoreductase 
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Gene cj0952c represents the N-terminus of a putative chemoreceptor, whereas 
cj0005c encoding one subunit of a sulphite: cytochrome c oxidoreductase (SOR). 
Since to my knowledge neither a chemoreceptor nor an enzyme from the energy 
metabolism has been connected to the infectivity of C. jejuni so far, these two 
genes were selected for further investigation. 
 
 
3.3 Characterization of cj0952c 
 
3.3.1 Transposon insertion in gene cj0952c does not alter the transcription 
of both upstream gene cj0953c as well as downstream gene cj0951c  
To determine the effect of the transposone insertion into gene cj0952c on the 
transcription of the upstream and downstream genes, reverse transcription PCR 
assays with the wild-type strain B2 and the mutant B2∆cj0952c. was performed 
The non-coding sequence between cj0953c and cj0952c has a length of 96 bp, 
and the gap between cj0952c and cj0951c is 263 bp in the clinical isolate B2, 
indicating a transcription of these three genes in a polycistronic fashion. For this, 
an altered transcription of especially the downstream located gene cj0951c cannot 
be excluded in case of a transposon insertion within gene cj0952c (Fig. 3.3). As it 
is shown in Fig. 3.4, transcription of cj0952c including the transposon, but also of 
cj0953c and cj0951c could clearly be proven in the mutant B2∆cj0952c, ensuring 
the invasion-deficient phenotype to be exclusively mediated by the insertion of the 
transposon into cj0952c. 
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Figure. 3.3 Genomic composition of cj0953c, cj0952c, cj0951c and cj0950c in the clinical C. 
jejuni  isolate B2 
In the above vectorial diagram the directions of the arrows denotes the transcriptional orientation 
of the genes. Primers used for RT-PCR analysis are shown as arrowheads. The Insertion site of 
the transposon is indicated. (Genbank accession number GU799572). 
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Figure 3.4 RT-PCR assays for the investigation of C. jejuni genes cj0951c, cj0952c and 
cj0953c in wild-type B2 strain and the mutant strain B2∆cj0952c  
The PCR amplicons are displaying the expected size for cj0953c (225 bp), cj0952c wild-type (267 
bp), cj0952c with the integrated transposon (2091 bp) and cj0951c (356 bp). To confirm RNA 
purification, PCR analysis on RNA templates under investigation yielded no amplicons, reflecting 
that DNA contaminations were completely removed (not shown). 
 
3.3.2 Functional restoration of C. jejuni B2∆cj0952c 
To restore the infectivity of the B2∆cj0952c mutant, cj0952c and cj0951c alone 
and cj0952c combined with cj0951c have been cloned into vector pRRC and were 
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channelled into B2∆cj0952c. Subsequent gentamicin protection assays on Caco2 
cells restored the parental phenotype only in the presence of both genes. Neither 
cj0952c nor cj0951c alone increased the mutant infectivity towards the wild-type 
B2. A graphical representation of altogether five independent experiments is 
shown in Fig 3.5.  
 
Unlike to wild-type strain B2, transcription of cj0952c in the complemented 
mutants is under control of a camR promoter. Real time RT PCR was performed in 
order to compare the transcription level of cj0952c in the wild-type and the 
complemented mutants. RNA samples adjustment was performed according to 
the crossing points of the 23S transcripts, respectively. Then, the cj0952c 
transcription level of the wild type strain, the mutant B2∆cj0952c complemented 
with cj0952c alone and complemented with cj0952c-cj0951c were determined. 
While the average crossing points of both complemented mutants were 20.49 
(cj0952c) and 20.18 (cj0952c-cj0951c), a specific signal for cj0952c from wild type 
strain was primal obtained at a crossing point of 32.44, clearly demonstrating a 
more than 4000 fold upregulation of cj0952c in the complemented mutants 
compared to the wild type strain. Consequently, a low transcription level of 
cj0952c under the control of the camR promoter could be excluded as a reason for 
the incomplete invasion phenotype of the mutant which only habours the cj0952c 
gene. 
 
In contrast to the clinical isolate B2 and C. jejuni strain NCTC 11168 where the 
putative chemoreceptor Cj0952c-Cj0951c is coated by two individual genes, the 
corresponding putative chemoreceptor in C. jejuni strain 81-176 is encoded by a 
single gene that covers the transmembrane domain, the HAMP domain and also 
the MCP domain. To further investigate whether the single gene of C. jejuni 81-
176 is able to complement B2∆cj0952c, was cloned it into pRRC and introduced 
the recombinant plasmid into the mutant. Thereby, the Caco2 cell infection was 
also restored up to the wild type level as summarized in Fig. 3.5. 
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In a next attempt to restore the invasiveness of the mutant B2∆cj0952c 
completely, a PCR fragment encompassing cj0952c-cj0951c-cj0950c was cloned 
into vector pRRC. Gene cj0950c is located downstream of cj0951c and the 
corresponding gene product is a putative lipoprotein of yet unknown function. It 
possesses a predicted signal peptide and shows homology to the heat shock 
protein HSLJ of E. coli. Since nothing is known about the role of this gene, a 
functional correlation of Cj0950c with Cj0952c and Cj0951c seemed to be 
possible. Gentamicin protection assays after introduction of the recombinant 
plasmid carrying all three genes obtained the recovery rates comparable to the 
mutant complemented with cj0952c-cj0951c indicating that Cj0950c is not in a 
functional correlation with Cj0952c and Cj0951c (Fig. 3.5 and Table 3.2). 
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Figure 3.5 Infection of Caco2 cells by wild-type strain B2, the mutant and the complemented 
mutants 
 Investigation revealed that the reconstitution of C. jejuni wild-type B2 strain invasiveness was 
achieved by complementation of B2∆cj0952c with cj0952c-cj0951c but not with cj0952c or cj0951c 
alone. The additional expression of Cj0950c had no influence on the recovery rate. 
Complementation of B2∆cj0952c with the corresponding gene of C. jejuni strain 81-176 
(B2∆cj0952c-comp-81-176) also shifted the infectivity of the mutant back to wild-type level. The 
experiments were carried out in triplicate and have been repeated five times. The error bars 
represent the standard deviation. 
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Table 3.2 The mean values of colonies recovered after five independent invasion 
experiments 
Strain Cfu/ml (x 105) Standard deviation (x105) 
   
wild-type B2 10.86 ± 0.86 
B2∆cj0952c 2.30 ± 0.53 
B2∆cj0952c comp-cj0952c 2.98 ± 0.28 
B2∆cj0952c comp-cj0951c 2.38 ± 0.26 
B2∆cj0952c comp-cj0952c-
cj0951c 
9.08 ± 1.00 
B2∆cj0952c comp-cj0952c-
cj0950c 
8.72 ± 1.04 
B2∆cj0952c comp-81-176 8.30 ± 0.37 
   
 
The parental strain B2 was significantly more invasive as compared to the reduced invasiveness of 
the mutant B2∆cj0952c and the mutants complemented with cj0952c or cj0951c (P<0.001). The 
variation of recovered colony numbers after invasion assays with mutants complemented with 
cj0952c-cj0951c, cj0952c-cj0950c or 81-176 was subsidiary (P>0.001). The standard deviations 
are indicated. See text for details. 
 
3.3.3 C. jejuni genes cj0952c and cj0951c of the clinical isolate B2 are 
translated into separate proteins  
C. jejuni genes cj0951c and cj0952c in the clinical isolated B2 as well as in the 
strain NCTC 11168 have been annotated to be pseudogenes, postulated to be 
translated into one functional protein by a speculated read through mechanism. To 
prove this hypothesis, PCR and reverse transcription-PCR with DNA and RNA of 
the parental strain B2 was carried out to detect alterations of the synthesized RNA 
e.g. a stop codon replacement of cj0952c to create one open reading frame for 
both genes. PCR and reverse transcription-PCR assays have been carried out 
with the primers Cj0952c-51cF and Cj0952c-51cR (listed in Table 2.1) which are 
spanning the 3’-region of cj0952c, the intergenic region and the 5’-domain of 
cj0951c. After sequencing of the PCR and RT-PCR products no differences 
between both amplicons could be detected. Neither the stop codon of cj0952c at 
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position 891663 of the genome was converted, nor other changes within the RNA 
sequence could be found contradicting the idea of a postulated read-through 
mechanism (data not shown). However, the analysis of the RT-PCR amplicon 
could justify that cj0951c and cj0952c are co-transcribed on one mRNA. 
Afterwards, genes cj0952c and cj0951c together were cloned into vector pRRC to 
answer the question whether these genes are translated as one protein or 
separately. For the proof of the recombinant protein expression, the primer 
corresponding to the 3’-end of cj0951c was extended by nucleotides representing 
a 6x His-tag (Table 2.2). After introduction of the recombinant plasmid into mutant 
B2∆cj0952c, the proteome was analysed by Western blotting. As a negative 
control, lysate of parental strain B2 was used. Thereby, a band corresponding to 
approximately 25 kDa was obtained, which is going along with the predicted 
protein size of Cj0951c but not with the expected size for Cj0952c-Cj0951c (58 
kDa), confirming that no read-through mechanism takes place in C. jejuni strain 
B2 (Fig. 3.6). For the confirmation of the immunoblot results, the experiment with 
other randomly chosen clones which harboured the recombinant plasmid was 
repeated. While in most of the clones expression of the corresponding protein 
could not be detected, the same 25 kDa bands were observed in two other 
clones. No band was found for a recombinant protein with the size of 
approximately 58 kDa (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
48 
 
 
                                                  
   
 
 
 
 
 
 
 
Figure 3.6 Detection of the recombinant protein in C. jejuni by Immunobloting 
Lane 1: molecular mass marker (molecular masses are indicated in kDa), lane 2: wild-type strain 
B2, lane 3: mutant B2∆cj0952c-comp-cj0952c-cj0951cHis. The observed protein molecule 
exhibited a molecular mass of approximately 25 kDa, which resembled the size of Cj0951c. No 
protein of a molecular mass of 58 kDa which would indicate a Cj0952c-Cj0951c composition could 
be detected. 
 
3.3.4 Decreased motility of C. jejuni B2∆cj0952c  
The chemotaxis machinery of a pathogen is known to be connected to motility 
(Hugdahl et al., 1988). For this, motility assays were used to investigate whether 
the mutant B2∆cj0952c has an altered phenotype. Thereby, a significantly 
reduced motility of the mutant compared to the parental strain B2 was determined. 
While the average diameter of the motility zone on semi-solid agar plates for B2 
was 47.4 mm ± 3.13, the mutant was clearly less motile with a mean diameter of 
30.6 mm ± 2.4 (P<0.0001). After complementation of the mutant with cj0952c or 
cj0951c, the motility remained reduced compared to the parental strain (30.6 mm 
± 2.9, 29.4 mm ± 2.3, P<0.0001). In contrast, when cj0952c together with cj0951c 
was introduced into the mutant, the motility of the wild-type was restored (46.6 
mm ± 3.2). Also the introduction of the corresponding gene of C. jejuni 81-176 into 
the mutant was successful to restore the parental phenotype. The motility zone of 
this revertant was 46.2 mm ± 2.8. The results are shown in Fig. 3.7 and 3.8. 
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                                              wild-type B2 strain      B2∆cj0952c                  B2∆cj0952c-                 
                                                                                                                          -cj0591c 
                                             
 
                                             B2∆cj0952c-                B2∆cj0952c-comp-      B2∆cj0952c- 
                                            comp-cj0952c               cj0952c-cj0951c         comp-81-176            
 
Figure 3.7 Motility of wild type strain, complemented mutants and cj0952c-mutant of C. 
jejuni strain B2 
The motility of B2∆cj0952c compared to wild-type strain B2 is not restored after introduction of 
cj0952c or cj0951c alone but only in combination of cj0952c and cj0951c or introduction of the 
corresponding gene from C. jejuni strain 81-176. Diagonal lines show the bacterial spread on the 
agar plates.  
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Figure 3.8 Motility zones of the wild-type strain B2, the mutant B2 ∆cj0952c and the 
complemented mutants 
Motility assays were carried out on semisolid 0.4 % Mueller Hinton agar plates inoculated with the 
indicated strains and incubated at 42 0C under microaerophilic conditions. Each experiment was 
performed seven times. See text for details. 
 
3.3.5 The C. jejuni proteins Cj0952c and Cj0951c alters the chemotactical 
behaviour of the pathogen in the presence of formic acid 
Chemotaxis assays were performed to investigate the chemotactical behaviour of 
the B2∆cj0952c mutant compared to that of the wild type strain B2 in order to 
investigate the function of Cj0952c-Cj0951c. For both strains, the accumulation of 
bacterial cells indicate chemoattraction around the plugs containing L-asparagine, 
L-aspartate, L-cysteine, fumarate, L-glutamate, D-lactate, L-(-)-malate, pyruvate, 
L-serine and succinate. Repulsion was demonstrated around the plugs containing 
cholic acid, deoxycholic acid, glycocholic acid and taucholic acid while no taxis 
response could be detected from PBS, L-fucose, and citrate. No significant 
differences in the extent of attraction or repulsion between wild type strain B2 and 
the mutant B2∆cj0952c could be identified (not shown). 
 
In contrast, in the case of formic acid a clear difference was observed. It was 
recently described that formic acid serves as chemoattractant for C. jejuni (Vegge 
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et al., 2009). In accordance with the results of this publication, we demonstrated a 
significant attraction halo for the parental strain B2 around the fomate-sodden 
paper disc, whereas for B2∆cj0952c, a biphasic halo with an inner repulsion zone 
surrounded by a diminished ring was observed (Fig. 3.9). The chemotactical 
behaviour was restored by complementation of the mutant with cj0952c-cj0951c 
or the corresponding gene from C. jejuni 81-176, but no restoration occurred 
when the mutant was complemented with cj0952c or cj0951c alone (Fig 3.9). After 
four independent experiments, the attraction zones from B2 and the mutant 
complemented with genes cj0952c and cj0951c as well as the gene from C. jejuni 
81-176 were 26.5 mm (± 2.6), 25 mm (± 2.5) and 25.5 mm (± 2.6), whereas the 
attraction zones of the mutant and the mutant complemented either with cj0952c 
or cj0951c alone were 10.2 mm (± 0.9), 10.0 mm (± 1.4) and 10.2 mm (± 1.7) as 
shown in Table 3.3. These results gave strong evidence that the genes cj0952c 
and cj0951c together are encoding a chemoreceptor which is involved in the 
chemotactical recognition of formic acid.  
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Figure 3.9 Photographical representation of the chemotactical behaviour of the investigated 
strains in the presence of formic acid 
1. wild-type strain B2, 2. B2∆cj0952c, 3. B2∆cj0952c-comp-cj0951c, 4. B2∆cj0952c-comp-cj0952c 
5. B2∆cj0952c-comp-cj0952c-cj0951c, 6. B2∆cj0952c-comp-81-176. Whereas wild-type strain B2, 
the mutant strain B2∆cj0952c complemented with cj0952c-cj0951c or the corresponding gene 
from C. jejini strain 81-176 clearly demonstrated chemoattraction around the formate sodden 
paper (green arrows), mutant B2∆cj0952c as the mutant complemented with cj0952c or cj0951c 
alone demonstrated a diversified chemotactical response: an inner repulsion zone (blue arrow) 
could be observed surrounded by a dense chemo attractant ring (green arrow).  
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Table 3.3 Chemoattraction zones of C. jejuni wild type strain, Complemented mutants and 
mutant are indicated in mm 
Strain  Chemoattraction zone 
(mm) 
Standard deviation 
(mm) 
   
wild-type B2 26.50 ± 2.64 
B2∆cj0952c 10.25 ± 0.95 
B2∆cj0952c comp-cj0951c 10.25 ± 1.70 
B2∆cj0952c comp-cj0952c 10.00 ± 1.41 
B2∆cj0952c comp-cj0952c-
cj0951c 
25.00 ± 2.58 
B2∆cj0952c comp-81-176 25.5 ± 2.64 
   
  
Chemotactical response of wild-type B2 and the mutants B2∆cj0952c complemented with cj0952c-
cj0951c or the respective gene from strain 81-176 are identical. In contrast, neither cj0952c nor 
cj0951c did restore the parental phenotype and exhibited significantly reduced chemotaxis 
(P<0.001) towards formic acid.  
 
3.3.6 The presence or absence of Cj0952c-Cj0951c does not affect the usage 
of formic acid 
Both, immunoblot analysis and molecular genetic approaches indicate that both 
proteins are translated separately and not as a single chemoreceptor. For further 
investigation of this unusual composed chemoreceptor, Cj0952c-Cj0951c we 
examined if this composition is correlated with the utilization of formic acid. The 
growth of the wild-type strain B2, the mutant, the cj0952c-cj0951c-complemented 
mutant and the mutant harbouring the single gene from C. jejuni 81-176 was 
measured in the presence of 10 mM formic acid. As a negative control, a formate 
dehydrogenase-deficient mutant of the B2 strain (B2∆fdh) was used. Thereby, no 
correlation of the chemoreceptor presence or composition and formic acid 
utilization was found. Wild type strain B2, the cj0952c-mutant and the 
complemented mutants showed exponentially identical proliferation while the 
growth of B2∆fdh was clearly reduced (Fig 3.10a). Increased growth of bacterial 
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strains under investigation in the absence of formic acid demonstrated 
comparable results although the growth of B2∆fdh was slightly shifted, eventually 
due to the presence of minor traces of formic acid in the MH broth which could not 
be metabolized by B2∆fdh (Fig 3.10b). 
 
        a)                                                                b) 
       
 
Figure 3.10 Growth curve with and without 10 mM formic acid 
Growth curve of parental strain B2 (♦), B2∆cj0952c (▲), B2∆cj0952c-comp-cj0952c-cj0951c (■), 
B2∆cj0952c-comp-81-176 (●) and (B2∆fdh (■) in MH broth supplemented (a), or not 
supplemented (b) with 10 mM formic acid. The y axis shows the optical density measured at 600 
nm. Error bars are indicated. See text for details. 
 
 
3.4 Characterization of cj0005c  
The gene product of cj0005c is encoding a molybdopterin oxidoreductase which, 
together with the monohaem cytochrome c oxidoreductase (cj0004c), constitutes 
a sulphite:cytochrome c oxidoreductase (SOR). Gentamicin protection assays on 
Caco2 cells with parental strain B2 and the mutant B2∆cj0005c clearly 
demonstrated the declined infectivity of the mutant compared to the wild type 
strain (Fig. 3.12.) The number of colonies recovered from wild type strain B2 was 
represented as 100%. The recovery rate of the mutant varied between 22 and 28 
%. 
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Figure 3.11 Recovery of C. jejuni bacteria after invasion assays on Caco2 cells 
(1) Parental strain B2, (2) the mutant of B2 carrying a transposon insertion in gene cj0005c 
(B2∆cj0005c). The recovery rate of bacteria from B2∆cj0005c is clearly reduced compared to the 
wild type strain. Given the number of colonies reclaimed from strain B2 is defined as 100 %, the 
number of colonies from B2∆cj0005c varied between 22 and 28 % with a mean value of 25 % (± 
6.5) and a P-Value of <0.0001. 
 
3.4.1 Construction of a cj0005c knock-out mutant and complementation of 
the mutant phenotype 
For validation and confirmation of the result described above, homologous 
recombination was applied to knockout the cj0005c gene in order to verify, that 
the invasion-deficient phenotype of C. jejuni B2∆cj0005c was due to the 
transposon insertion into gene cj0005c and not to other genetic rearrangements 
somewhere in the genome. A recombinant plasmid carrying the cj0005c gene 
interrupted by a kanR gene cassette was introduced into strain B2. Subsequent 
PCR analysis were performed with genomic DNA from the obtained C. jejuni 
clones for the detection of an amplicon corresponding of the size of cj0005c 
including the aphA-3 cassette (B2::cj0005c) (Fig. 3.12b). Using gentamicin 
protection assays, the knock-out mutant B2::cj0005c confirmed the phenotype of 
C. jejuni strain B2 harbouring the transposon within cj0005c, which strengthens 
the finding that the mutation of cj0005c is responsible for the invasion-deficient 
phenotype (Fig. 3.12c). For the restoration of the phenotype of parental strain B2, 
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cj0005c was cloned into C. jejuni expression plasmid pRRC and introduced into 
B2::cj0005c to obtain B2::cj0005c-comp-cj0005c (Fig. 3.12a). Afterwards, the 
invasion assays were repeated with wild-type strain B2, both mutants and the 
complemented knock-out mutant. The number of B2 colonies recovered was 
defined as 100 %, the mean values of invasion capacities of B2∆cj0005c, 
B2::cj0005c and B2::cj0005c-comp-cj0005c were 25 %, 29.8 % and 85.6 % 
respectively. Since the P-values of both mutants were less than 0.0001, the 
altered invasion capacities were strongly significant. In contrast, the P-value for 
the complemented knock-out mutant to be less invasive was only 0.16, which 
showed no significant difference compared to the wild-type strain B2. (Fig. 3.12c). 
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Figure. 3.12 Genome arrangements, verification of cloning procedures and invasion assays 
of the strains under investigation 
(1) parental strain B2. (2) B2 with transposon insertion in cj0005c (B2∆cj0005c), (3) cj0005c 
knock-out mutant (B2::cj0005c), (4) complemented knock-out mutant (B2::cj0005c-comp-cj0005c). 
(a) Genome disposals of the investigated bacterial strains. Primers Cj0005cF and Cj0005cR for 
the amplification of cj0005c are shown as arrowheads. The primer Kan1 that binds to the 5’-end of 
the kanamycin resistance cassette is illustrated as an arrow. (b) Detection of the native gene, the 
respective mutants and the complemented strain by PCR analysis. The native cj0005c gene has a 
size of 1239 bp (1). Insertion of the transposon and insertion of the kanamycin resistance gene 
yielded PCR-fragments of 2932 bp (2) and 2623 bp (3), respectively. PCR analysis of the 
complemented knock out mutant using the primers Cj0005cF and Cj0005cR revealed only the 
amplification of the wild type gene, probably because of its smaller size (not shown). To detect 
both, the gene with the kanamycin resistance cassette (2234 bp) and the native gene (1239 bp), 
PCR analysis with primers Cj0005cF and Cj0005cR and a third primer (Kan1) corresponding to the 
5’-end of the aphA-3 gene were carried out (4). (c) Gentamicin protection assays. Invasion-
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reduced phenotype of B2∆cj0005c could be confirmed after specific knock-out of cj0005c 
(B2::cj0005c). Complementation of the knock-out mutant, in turn, reconstituted the parental 
phenotype. See text for details. 
 
3.4.2 The loss of a functional SOR leads to reduced growth in the presence 
of sodium sulphite  
In order to measure the effect of the SOR knock-out gene product on the 
proliferation of C. jejuni, growth experiments were carried out, both, in the 
presence and the absence of sodium sulphite. No distinguishable differences 
were found in the growth of the parental strain B2, the knock-out mutant 
B2::cj0005c and the complemented mutant in the absence of sodium sulphite. In 
contrast, in the presence of 10 mM sodium sulphite, the growth of the mutant 
exhibited a clear reduction compared to B2 and B2::cj0005c-comp-cj0005c (Fig. 
3.13). 
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Figure. 3.13 Growth curve in the presence and absence of 10 mM Na2SO3  
Parental strain B2 (♦), B2::cj0005c (▲) and complemented mutant B2::cj0005c-comp-cj0005c (■) 
not supplemented ( a) and supplemented (b) with 10 mM Na2SO3. The optical density measured at 
600 nm is shown on the y axis. 
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3.4.3 The absence of a functional SOR reduces the motility of C. jejuni 
As reduced growth in case of an incomplete energy metabolism was detected, It 
was examined that if the motility of the pathogen was also diminished, since 
motility is known to be energy consuming. When the motility of the parental strain 
B2, the knock-out mutant and the complemented knock-out mutant was compared 
by using semi-solid motility medium, a loss of motility of the mutant B2::cj0005c 
could be clearly detected which could be reconstituted completely to the wild-type 
strain motility after introduction of a functional cj0005c gene into the mutant. The 
results of four independent motility assays performed are summarized in Fig. 
3.14a. The mean diameter zone of motility for strain B2 was 40 mm ± 4.6, while 
the motility of the mutant B2::cj0005c was significantly reduced (18.2 mm ± 1.7, 
P<0.01) compared to B2. After introduction of a functional copy of gene cj0005c, 
the revertant returned to wild-type motility level with zone diameters of 38.7 mm ± 
4.1 in average. These findings raised the idea that the reduced infectivity is first of 
all caused by a lack of motility as a result of a limited energy metabolism. 
 
3.4.4 Reduced motility conduces to decreased invasiveness 
To investigate whether the reduced motility is the sole reason for the strongly 
reduced invasion capacity of the cj0005c-deficient mutant or if any other factors 
are involved, motility was simulated by centrifugation of the bacteria onto the 
Caco2 host cells. Afterwards, gentamicin protection assays were performed again. 
Thereby, fixing the number of colonies recovered from wild-type strain B2 as 100 
%, we detected 48.6 % of colonies (P<0.01) after centrifugation of the knock-out 
mutant B2::cj0005c, while the number of colonies recovered of the complemented 
mutant was 87 % in average which was not significantly different compared to the 
wild-type strain (Fig. 3.14b). Compared to the outcome of the gentamicin 
protection assays without centrifugation (Fig. 3.11) an increase of mutant colonies 
from 25 % up to 48.6 %.was clearly detected This finding was interesting, since 
one would have expected to shift infectivity of the mutant up to wild-type level after 
absorbing motility as a virulence factor in case that reduced motility is the only 
reason for diminished infectivity. But this result indicates that the reduced motility 
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is one, but not the only factor responsible for the clearly reduced invasiveness of 
the cj0005c-deficient mutant.  
 
(a)                                                                    (b) 
 
 
Figure. 3.14 Motility assays and gentamycine protection assays after centrifugation 
1. Wild-type strain B2, 2. knock-out mutant B2::cj0005c, 3. complemented mutant B2::cj0005c-
comp-cj0005c. (a) Motility assays. The diameter of the motility zones are indicated as bars. The 
cj0005c-deficient mutant possesses a clearly reduced motility compared to parental strain B2 
which could be complemented after introduction of an intact copy of gene cj0005c. (b) Gentamicin 
protection assays after centrifugation of the bacteria onto Caco2 cells. Defining the number of 
isolate B2 colonies recovered as 100 %, the percentage of colonies of the knock-out mutant 
B::cj0005c colonies was 48.6 % in average, whereas complementation of the mutant restored the 
parental phenotype to 87 %. See text for details. 
 
3.4.5 Diminished adherence contributes to reduced invasiveness 
In order to characterize the process of invasion more in detail, It was investigated 
if already the adherence of the energy deficient mutant is hampered. Therefore, 
adhesion assays of wild-type isolate B2, the mutant B2::cj0005c and the 
complemented mutant were performed. To mimic the different motility of the 
bacteria under investigation, again, the bacteria were centrifuged onto the Caco2 
cells. Thereby, an adhesion-deficient phenotype of the mutant could be clearly 
detected which could be restored to wild-type behaviour after complementation. 
Taken the number of colonies recovered from parental strain B2 as 100 %, the 
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mean value of colonies from the mutant B2::cj0005c was 67 % (± 5.1, P<0.0001) 
in contrast to B2::cj0005c-comp-cj0005c with a rate of recovery of 94 % (± 2.2) 
(Fig. 3.15). 
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Figure 3.15 Adhesion assay  
1. Wild-type strain B2, 2. knock-out mutant B2::cj0005c, 3. complemented mutant B2::cj0005c-
comp-cj0005c. The adherence of the mutant B2::cj0005c onto Caco2 cells was incomplete 
compared to the wild-type strain. The percentage of adhered colonies of the mutant was only 67 % 
compared to wild-type isolate B2. See text for details. 
 
3.4.6 The transcription of virulence associated genes is down-regulated in 
the absence of a functional SOR 
After the detection that the reduced motility is one, but not the only reason for the 
decreased invasiveness of the mutant which is deficient in its energy metabolism, 
the transcription level of genes known to be involved in virulence of the pathogen 
was examined by semi-quantitative real time RT-PCR. The genes examined were 
the heat shock proteins groEL and dnaJ (Thies et al., 1999; Konkel et al., 1998), 
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the chemotaxis regulator gene cheY (Yao et al., 1997), and the putative 
chemoreceptor tlp7 (Marchant et al., 2002), also genes known to be crucial for the 
process of binding and adhesion, like the gene for the fibronectin binding protein 
cadF (Konkel et al., 1997), as well as genes peb1a and jlpA known to encode 
adhesion-relevant proteins (Pei and Blaser, 1993; Jin et al., 2001). Furthermore, 
the transcription level of the Campylobacter invasive antigen ciaB (Rivera-Amill et 
al., 2001; Konkel et al., 2004), the cytothelial distending toxin cdtB (Pickett and 
Whitehouse, 1999) and flaA (Guerry et al., 1991) were compared. Furthermore 
the transcription of genes responsible for O-glycosylation of the flagellum by the 
synthesis of pseudaminic acid (PseAc) and legionaminic acid (LegAm) was 
examined (Logan et al., 2008). Thereby, a statistically significant 5.16 fold down-
regulation of dnaJ in the mutant compared to the transcription level of this gene in 
wild-type strain B2 was clearly detected (P<0.001). Genes ptmB, ptmC and ptmE, 
which are involved in the synthesis of legionaminic acid (LegAm) were 
significantly down-regulated between factor 4.31 to 7.67 (P<0.0001) while other 
genes which are part of the legionaminic acid metabolism were downregulated 
significantly as well, but to a lesser extent (ptmA, ptmF or ptmG). In contrast, the 
transcription level of all the other genes studied was not changed significantly 
irrespective of the presence or absence of SOR. The results are summarized in 
Table 3.4.The RNA level of mutant complemented with the intact version of 
cj0005c was examined, it was observed which that the crossing point for the 
respective genes which were almost identical with the wild type (Table 3.5) 
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Table 3.4. Transcription level of selected virulence-associated genes from C. jejuni in wild-
type strain B2 and mutant B2::cj0005c 
Gene B2::cj0005c B2 wild-type        Function 
 Cp (mean value) Cp (mean value) Fold change  
(t-test P-value) 
 
     
GroEL 9.79 (± 0.002) 9.52 (± 0.02) 1.20 (0.03) Heat-shock response 
DnaJ 23.34 (± 0.09) 20.97 (± 0.05) 5.16 (0.0001) Heat shock response 
DnaK 12.8 (± 0.03) 12.64 (± 0.001) 1.11 (0.03) Heat shock response 
CheY 12.87 (±0.0002) 11.86 (± 0.87) 2.01 (0.13) Chemotaxis response 
regulator 
tlp7 6.36 (± 0.02) 6.66 (± 0.02) 1.23 (0.07) Chemotaxis receptor 
CadF 11.70 (± 0.008) 11.26 (± 1.15) 1.35 (0.51) Fibronectin binding outer 
membrane protein 
peb1a 9.66 (± 0.05) 9.78 (± 0.02) 1.08 (0.52) Periplasmic binding 
protein 
JlpA 13.84 (± 2.4) 13.44 (± 1.8) 1.31 (0.75) Surface-exposed 
lipoprotein 
CiaB 20.94 (± 0.08) 21.49 (± 0.09) 1.46 (0.08) Campylobacter invasive   
antigen B 
CdtB 13.55 (± 0.86) 13.84 (± 0.05) 1.22 (0.62) Cytolethal distending toxin 
B 
FlaA 11.52 (± 0.04) 11.98 (± 0.001) 1.37 (0.01) Flagellum 
FlpA 15.76 (± 0.27) 15.1 (± 0.10) 1.58 (0.10) Adhesin 
PorA 07.23 (± 0.50) 6.63 (± 0.66) 1.51 (0.058) Adhesin 
PglE 
PtmA 
16.39 (± 0.71) 
22.29 (± 0.55) 
16.02 (± 1.03) 
20.79 (± 0.17) 
1.29 (0.64) 
2.82 (0.0001) 
Protein glycosylation 
LegAm synthesis 
PtmB 19.40 (± 0.77) 16.83 (± 0.01) 5.93 (0.0001) LegAm synthesis 
PtmC 18.31 (± 0.47) 16.20 (± 1.19) 4.31 (0.0001) LegAm synthesis 
PtmD 20.53 (± 0.59) 20.16 (± 0.72) 1.29 (0.39) LegAm synthesis 
PtmE 18.11 (± 0.06) 15.17 (± 0.38) 7.67 (0.0001) LegAm synthesis 
PtmF 19.74 (± 0.50) 18.30 (± 0.89) 2.71 (0.0001) LegAm synthesis 
PtmG 19.16 (± 0.25) 17.64 (± 0.15) 2.86 (0.0001) LegAm synthesis 
PtmH 20.17 (± 0.26) 18.82 (±0.12) 2.54. (0.017) LegAM synthesis 
PseA 23.04 (± 0.48) 21.86 (± 0.19) 2.26 (0.016) PseAc synthesis 
PseB 20.71 (± 0.02) 21.29 (± 0.42) 1.49 (0.11) PseAc synthesis 
PseC 20.74 (±  0.05) 20.74 (± 0.016) 0.00 (0.80) PseAc synthesis 
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PseD 23.30 (± 0.60) 21.64 (± 0.20) 3.16 (0.0001) PseAc synthesis 
PseE 21.35 (± 0.21) 19.8 (± 0.05) 2.92 (0.067) PseAc synthesis 
Strongly downregulated genes are indicated in bold. See text for details. 
In contrast, when we compared the transcription level of the genes which are 
down-regulated in the complemented mutant with the transcription level of the 
respective genes in the parental strain, the values for the crossing points were 
almost identical. (Table 3.5). 
 
Table 3.5. Restored transcription levels of genes in the complemented mutant compared to 
parental strain B2 
Gene B2::cj0005c 
comp-cj0005c 
 
Fold change 
(Compared to wild-type B2)
 
 Cp (mean value) (t-test P-value) 
ptmA 20.87 (±  0.05) 1.05 (0.571) 
PtmB 17.45 (± 0.079) 1.53 (0.071) 
PtmC 16.63 (± 0.87) 1.34 (0.407) 
PtmE 15.6 (± 0.20) 1.34 (0.316) 
PtmF 19.74 (± 0.50) 2.71 (0.014) 
PtmG 17.62 (± 0.07) 1.01 (0.127)) 
PseD 22.39 (± 0.60) 1.68 (0.242) 
DnaJ 21.11 (± 0.06) 1.01 (0.071) 
 3.4.7 Reduced autoagglutination of mutant B2::cj0005c 
Recently, Howard and coworkers (2010) reported that C. jejuni mutants deficient 
in gene cj1324 (ptmG) or genes cj1321-1325/6, which are responsible for the 
legionaminic acid synthesis, showed a significantly decreased capacity for 
autoagglutination. When the mutant B2::cj0005c was compared with the wild-type 
strain B2, a significant down-regulation of ptmG-transcription and of other genes 
of the legionaminic acid metabolism was detected. For this, the competency of 
autoagglutination of mutant B2::cj0005c compared to wild-type strain B2 was 
investigated. As is shown in Fig 3.16, the autoagglutination ability of the mutant 
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strain is actually diminished. The percent autoagglutination of wild-type strain B2 
and complemented mutant was 74.24 % (± 0.25) and 73.65 % (± 0.22), 
respectively, whereas the mutant B2::cj0005c had a remaining autoagglutination 
level of only 37.02 % (± 0.61) which was a significant reduction compared to B2 
(P<0.0001).  
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Figure. 3.16. Autoagglutination 
Autoagglutination of mutant B2::cj0005c was compared to wild-type strain B2 and complemented 
mutant. 1. wild-type strain B2, 2. knockout mutant B2::cj0005c, 3. complemented mutant 
B2::cj0005c-comp-cj0005c. See text for details 
 
 
 
 
 
 
 
 
 
 
 
66 
 
4. DISCUSSION 
 
Transposon insertions are interrupting the function of genes and are thus a tool for 
generating random mutations (Spradlingand and Rubin, 1982). For this, 
transposon mutagenesis techniques have also been used in C. jejuni research to 
detect genes which contribute to the pathogenicity of the bacterium (Colegio et al., 
2001; Golden et al., 2000). Thereby, motility deficient mutants have been 
examined which carried the transposon in genes that have not been correlated 
with motility but in genes which belong to the chemotaxis machinery (Golden and 
Acheson, 2002; Hendrixson et al., 2001). Furthermore, transposon mutagenesis 
coupled with reporter assays have been used for the identification of genes 
involved in flageller regulation at the beginning of the flagellar transcription 
cascade (Hendrixson and DiRita, 2003) and were used to study the nature of 
Campylobacter colonization in the gastrointestinal tract of chickens (Grant et al., 
2005), including the gene encoding the methyl-accepting chemotaxis protein docB 
(tlp 10) (Hendrixson and DiRita, 2004). By using transposon-based mutations 
several genes were identified that play an important role for host cell invasion and 
also for C. jejuni colonization (Novik et al., 2010). Javed and coworkers (2009) 
used transposon mutagenesis in a hyper-invasive clinical isolate of C. jejuni to 
detect 26 mutants with a clearly reduced invasion capacity. By applying 
transposon mutagenesis, C. jejuni genes which play an important role for the 
molecular basis of resistance to polymyxin and natural antimicrobial peptides 
could be identified (Lin et al., 2009). 
  
The present study was undertaken to uncover additional genes of C. jejuni that 
are associated with the invasion process. A total of 660 clones of an existing 
transposon-based library of clinical C. jejuni isolate B2 were screened for reduced 
invasion of Caco2 cells. Thereby, a clone with a transposon insertion in gene 
cj0952c, which shows a strong homology to genes representing methyl-accepting 
chemotaxis proteins (MCPs), was detected. Like all other motile bacteria, C. jejuni 
has the competence to sense its external environment through chemical 
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gradients. Cellular motility and chemotaxis have been connected to virulence of 
pathogenic bacteria and play a vital role in colonization and invasion of the host 
intestinal tract (Josenhans and Suerbaum, 2002). Initially, cj0952c was thought to 
be a pseudogene, since the immediately downstream located gene cj0951c which 
is encoding a signaling domain, together with Cj0952c, might act as a complete 
chemoreceptor. Performing BLASTN analysis in the NCBI database, in the C. 
jejuni strains NCTC 11168, CF93-6 and 84-25, the mentioned chemoreceptors is 
composed of two single genes. Similarly, the genes cj0951c and cj0952c are 
present separately in the clinical isolate B2. On contrary, in strains 81-176 or 
81116, the corresponding chemoreceptor is the product of only one single gene 
encompassing the MCP domain, the transmembrane domain and the signaling 
domain as well. To date, cj0952c has not been described functionally, and was 
only demonstrated to be up-regulated during the process of chicken colonization 
(Woodall et al., 2005). As in many other bacteria, C. jejuni resides genes 
indispensable for chemotaxis like cheA, chew, cheY and MCPs receptors. It is 
suggested that interaction of CheW and CheV is necessary to regulate CheA 
activity via the MCPs (Rosario et al., 1994). Moreover, it has been shown that C. 
jejuni colonization is only possible with the help of chemotactic-mediated motility 
(Takata et al., 1992; Yao et al., 1994). Altogether ten genes encoding chemotaxis 
proteins known as transducer-like proteins (Tlps) were identified in the genome of 
C. jejuni. These ten Tlps can further be classified according to their predicted 
domain organization into three different groups (A-C) (Marchant et al., 2002). The 
Tlp group A is further divided in subgroups Tlp1, 2, 3, 4, 7 and 10. Thereby, Tlp1 
has been demonstrated to be the aspartate chemoreceptor of C. jejuni and plays 
a role in the colonization of the intestinal tract (Hartley-Tassell et al., 2010). 
 
Predicted structures of group A Tlps shows classical MCPs organization, identical 
to that of E. coli MCPs, with a periplasmic sensory domain, which is extremely 
variable between different receptors, two transmembrane domains, and the C-
terminal cytoplasmic signaling domain (Marchant et al., 2002). Cj0952c-Cj0951c 
(Tlp7) belongs to group A chemoreceptors which are MCPs and having four 
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domains that consist of a N-terminal transmembrane domain, a periplasmic 
ligand-binding domain, a HAMP domain and a C-terminal cytoplasmic signaling 
domain at the C-terminal end, in which the HAMP domain converts the ligand-
induced conformational changes into kinase controlling signals. (Aravind and 
Ponting, 1999; Butler and Falke, 1998; LeMoual and Koshland, 1996; Williams 
and Stewart, 1999). Cj0951c shows strong homologies with the cytoplasmic 
signaling domain of MCPs that possess an adaption region with internal 
methylation sites. This flexible region mediates the interaction with kinase CheA 
and chemotaxis protein CheW (Hazelbauer et al., 2008). 
 
In this study, it was shown that transposon insertion in gene cj0952c does not 
affect the transcription of the adjacent gene cj0951c. In order to create a 
functional chemoreceptor both genes have probably to be transcribed on the 
same RNA to allow the aggregation of both subunits to obtain one functionally 
active chemoreceptor.  
 
To answer the question whether both genes are translated as one protein, the 
corresponding genes in trans in C. jejuni was expressed. For the detection of the 
recombinant protein a 6x His-tag was added to the C-terminus of Cj0951c. 
Subsequent western blot analysis only detected a protein that corresponded to 
the size of Cj0951c but not to the size of a protein that would indicate a protein 
composed of Cj0952c and Cj0951c. For this, in C. jejuni strain B2, a non-covalent 
interaction of both subunits might be postulated for the creation of a functional 
chemoreceptor. 
 
Host-pathogen interaction is a prerequisite for C. jejuni pathogenicity and is 
mediated by the chemotaxis system as it directs the pathogen towards the host 
cell at the site of entry. Gene alterations in the chemotaxis apparatus reduce the 
strength of C. jejuni to infect human and chicken cells as well. Mutant strains 
which are deficient in cj0262 (Tlp4, docC) or cj0019 (Tlp10, docB) revealed a 
decreased colonization of the chicken intestinal cells ( Hendrixson and DiRita, 
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2004). In additional, the chemoreceptors Tlp1 (cj1506), Tlp2 (cj0144), Tlp3 
(cj1564), Tlp4 and Tlp10 are important for the disease-causing ability of the 
invading pathogen (Golden and Archeson, 2002; Hendrixson and DiRita, 2004; 
Vegge et al., 2009). However, less is known about the chemoreceptors of C. 
jejuni, so far.  
 
Recently, Cj1506c (Tlp1) of C. jejuni was identified as the aspartate 
chemosensory receptor and was the first chemoreceptor of this pathogen 
described with respect to its particular ligand (Hartley et al., 2010). In this study it 
has described that the inactivation of gene cj0952c changes the chemotactic 
behaviour of C. jejuni with regard to formic acid. While in the wild-type strain 
formic acid was clearly a chemoattractant, the mutant showed a biphasic halo 
together with an inner repulsion zone which was surrounded by a diminished ring. 
The reduced, but still measurable attraction of the mutant towards formic acid 
might be mediated by the energy taxis system of the pathogen which consists of 
the two proteins CetA and CetB that act together as energy taxis receptors. In this 
system, changes in the redox state of the electron transport chain are sensed by 
CetB and are subsequently relayed to CetA via direct interaction. CetA further 
transduces the signal to the chemotactic machinery and leads to changes in the 
direction of motility (Hendrixson et al., 2001; Elliot and DiRita, 2008). Energy taxis 
has been shown to direct C. jejuni towards attractants which serve as carbon 
sources, electron acceptors and, as in the case of formic acid, electron donors 
(Vegge et al., 2009). The formation of an inner repulsion zone might suggest that 
another chemosensory mechanism exists that recognizes formic acid as a 
chemorepellent.  
 
The enzyme formate dehydrogenase catalizes the oxidation of formate to CO2, 
protons and electrons which are injected into the respiratory chain and, thus, 
serves as an electron donor. The enzyme consists of four subunits which are 
encoded by the fdhABCD operon of C. jejuni encompassing the genes cj1511c-
cj1508c (Weerakoon et al., 2009). In this study it was shown that the C. jejuni 
70 
 
chemoreceptor for the detection formic acid is composed by the proteins Cj0952c 
and Cj0951c. To investigate whether this unusual composition of the 
chemoreceptor is going along with the utilization of its particular chemoattractant, 
the growth curves in the presence and absence of formic acid was carried out. 
Thereby any differences in the proliferation of wild-type strain B2, the mutant 
B2∆cj0952c and the complemented mutant was not detected. Interestingly, the 
growth of the bacteria in general (except of B2∆fdh), significantly promoted in the 
presence of formic acid in medium, indicating that the generation of electrons by 
the oxidation of formic acid is an important process in the context of the energy 
metabolism of C. jejuni. 
 
Many prokaryotes possess a complex electron transport chain to cope their 
energy requirement. Similarly, C. jejuni has a highly complex respiratory chain that 
allows the pathogen to use a variety of electron donors like, succinate, malate, D-
lactate, hydrogen, formate, NAD(P)H and sulphite (Kelly, 2001; Sellars et al., 
2002; Myers and Kelly, 2005; Weerakoon et al., 2009). In C. jejuni resides an 
enzyme named molybdenum-containing sulphite: cytochrome c oxidoreductase 
(SOR) which is involved in the oxidation of sulphite to sulphate and the release of 
electrons which are used as fuel in the respiratory chain. SOR is the ultimate 
product of two genes including cj0005c and cj0004c and has similarity to the 
corresponding enzyme of Starkeya novella (Jonathan and David, 2005). Gene 
cj0004c is responsible for encoding the monohaem cytochrome c subunit, 
whereas cj0005c encodes the molybdopterin oxidoreductase. Both subunits of the 
SOR work in a unifunctional manner and catalyze the conversion of sulphite to 
sulphate in the presence of oxygen to generate electrons which are used in the 
respiratory chain after the bc1 complex at the level of cytochrome c (Kappler et al., 
2000; Kappler and Dahl, 2001; Myers and Kelly, 2005). 
 
In this work, a cj0005c-deficient mutant of C. jejuni with strongly diminished 
motility function of the pathogen and, therefore, a reduced ability to invade the 
host cells was investigated, which, in contrast to other motility deficient strains, is 
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limited in its energy metabolism instead of the flagellar apparatus. C. jejuni motility 
function is the key regulator to infect the assigned host, so we can say that motility 
is the main player responsible for C. jejuni colonization. In the recent years, 
several studies have documented the impact of genes and gene products of the 
flagellar apparatus with particular reference to the colonization or invasion of host 
cells. Morooka and coworkers (1985) described that motility-deficient strains of C. 
jejuni were eliminated from the intestinal tract of suckling mice, while a motility-
competent strain colonized the lower portion of the intestine, the caecum as well 
as the colon. Pathogen colonization in this animal was shown to depend on the 
flagella, because a non-flagellated mutant was not able to survive inside the rabbit 
intestine (Pavlovskis et al., 1991). In addition, the chicken intestinal tract was 
shown to be invaded only by sound motile strains of C. jejuni, reflecting an intact 
flagellum to be an important invading factor of the pathogen to cause disease 
(Nachamkin et al., 1993). Mutants can be generated by homologous 
recombination procedures which can be subsequently investigated in in vitro cell 
culture experiments for their ability to infect the host cells. Thereby, the role of 
motility in the invasiveness of C. jejuni could also be established (Wassenaar et 
al., 1991; Yao et al., 1994; Szymanski et al., 1995; Konkel et al., 2004). In 
addition, numbers of coding sequences and gene products have been described 
that attributed to the flagellum function for successful motility which is further 
responsible for motility-mediated pathogen infectivity (Hendrixson, 2008).In order 
to exclude motility as a virulence factor, the wild-type strain B2, the mutant and 
the complemented mutant were centrifuged directly onto the host cells. 
Interestingly, the infectivity of the mutant up to 48.6 % was only restore compared 
to the parental strain, which clearly indicated that motility was only one, but not 
the only reason for the incomplete infectivity of the mutant. For this, it was 
investigated whether the energy-deficient genotype of the mutant has some effect 
on the transcription level of other virulence-related genes. Semi-quantitative real 
time RT-PCR was used to investigate selected genes associated with stress 
response, motility, chemotaxis as well as binding and adhesion. In addition, genes 
essential for the invasion of host cells by C. jejuni were examined. As a result of 
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these investigations, a significant down-regulation of dnaJ and of genes for the 
synthesis of legionaminic acid in the mutant compared to parental strain B2 was 
detected.  
 
In most prokaryotes and eukayotes the DnaJ (Hsp 40) proteins reside as co-
chaperones of their corresponding heat shock protein 70 (Hsp 70) partners 
(DnaKs) (Genevaux et al., 2007). The DnaJ family proteins have an N-terminal J-
domain of approximately 70 amino acids (Hennessy et al., 2005). The molecular 
function of DnaJ is the interaction of the substrate-bound cochaperone with its 
corresponding ATP-bound DnaK protein via J-domain and ATPase domain, which 
mediates a subsequent conformational change of DnaK. Conformational change 
of DnaK, in turn, stimulates ATP-hydrolysis and is leading to high affinity and low 
exchange rates for its particular substrate (Liberek et al., 1991; Karzai et al., 1996; 
Laufen et al., 1999). DnaJ co-chaperones in C. jejuni were shown to be an 
integral part of the heat shock response of the invader (Konkel et al., 1998). The 
DnaJ protein sequences of C. jejuni exhibit 60.8 % homology with the 
corresponding protein of E. coli. It is also established that the function of an E. coli 
dnaJ deletion mutant could be restored by complementing the corresponding 
gene from C. jejuni strain F38011 (Konkel et al., 1998).  
 
The acetoamidino form of legionaminic acid (LegAm) together with pseudaminic 
acid (PseAc) are O-linked to the flagellin protein of most C. jejuni strains (Logan et 
al., 2008). Previously, eight genes have been reported to be involved in the 
legionaminic acid synthetic pathway including cj1324 (ptmG), cj1325/6 (ptmH), 
cj1327-cj1330 (ptmC, ptmD, ptmE, ptmF), cj1331 (ptmB) and cj1332 (ptmA) gene 
(McNally et al., 2007). Although the role of O-glycosylation by legionaminic acid is 
still not well defined, recent investigations have given a first insight into its 
biological relevance (Howard et al., 2010). In their report they describe a cj1324-
deficient mutant, which is fully motile but has a decreased autoagglutination and 
biofilm formation due to the lack of two legionaminic acid glycan modifications. 
Furthermore, this mutant possesses a diminished activity to invade chicken cells. 
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When the transcription level of the LegAm genes in the cj0005c mutant was 
investigated, only a 2.86 fold down-regulation of cj1324 (ptmG) was documented. 
In this study a reduced autoagglutination was shown, but the formation of biofilm 
was not affected (data not shown). In contrast to the study from Howard et al., 
(2010) the transcription level of all genes known to be involved in the synthesis of 
legionaminic acid was examined. Thereby a strong down-regulation of ptmB 
(cj1331), ptmC (cj1327) and ptmE (1329), in the cj0005c-deficient mutant was 
detected and a weaker down-regulation of genes ptmA (cj1332), ptmF (cj1330), 
and ptmG (cj1324) compared to wild-type strain B2. Although transcription 
analysis was not carried out that covered the whole genome status of the 
pathogen, alterations in the transcription level of other genes are likely. 
Nevertheless, the results were obtained so far might indicate a correlation of the 
affected biological properties of the mutant (e.g. diminished adhesion and 
autoagglutination) with the downregulation of genes of the LegAm metabolism.  
Taken together, two factors of C. jejuni that contribute to host cell invasion by two 
different mechanisms was identified. In the case of cj0952c, a chemoreceptor 
subunit is deleted, which probably reduces the proper accession of C. jejuni to its 
host cell by a restricted response towards the chemoattractant formic acid and, 
consequently, by reduced motility. In contrast, the cj0005c-deficient mutant is 
limited in motility and adhesion probably due to its narrowed energy metabolism. 
 
.  
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